Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Previous issues

Page Path
HOME > Browse > Previous issues
16 Previous issues
Filter
Filter
Article category
Keywords
Authors
Volume 35(3); June 2011
Prev issue Next issue
Reviews
Diabetes and Cancer: Is Diabetes Causally Related to Cancer?
Sunghwan Suh, Kwang-Won Kim
Diabetes Metab J. 2011;35(3):193-198.   Published online June 30, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.3.193
  • 4,500 View
  • 38 Download
  • 82 Crossref
AbstractAbstract PDFPubReader   

Diabetes mellitus is a serious and growing health problem worldwide and is associated with severe acute and chronic complications. Moreover, epidemiologic evidence suggests that people with diabetes are at significantly higher risk for many forms of cancer. Several studies indicate an association between diabetes and the risk of liver, pancreas, endometrium, colon/rectum, breast, and bladder cancer. Mortality is also moderately increased in subjects with diabetes. Common risk factors such as age, obesity, physical inactivity and smoking may contribute to increased cancer risk in diabetic patients. Hyperinsulinemia most likely favors cancer in diabetic patients as insulin is a growth factor with pre-eminent metabolic as well as mitogenic effects, and its action in malignant cells is favored by mechanisms acting at both the receptor and post-receptor level. The effect of diabetes treatment drugs, aside from metformin, on cancer is not conclusive. In order to fight the perfect storm of diabetes and cancer, strategies to promote primary prevention and early detection of these conditions are urgently needed.

Citations

Citations to this article as recorded by  
  • Proinsulin C-peptide inhibits high glucose-induced migration and invasion of ovarian cancer cells
    Eun-Bin Kim, Hye-Yoon Jeon, Yung-Taek Ouh, Ah-Jun Lee, Chan-Hee Moon, Sung Hun Na, Kwon-Soo Ha
    Biomedicine & Pharmacotherapy.2024; 172: 116232.     CrossRef
  • Glycemic traits and colorectal cancer survival in a cohort of South Korean patients: A Mendelian randomization analysis
    So Yon Jun, Sooyoung Cho, Min Jung Kim, Ji Won Park, Seung‐Bum Ryoo, Seung Yong Jeong, Kyu Joo Park, Aesun Shin
    Cancer Medicine.2024;[Epub]     CrossRef
  • The Association of Glycemic Index, Glycemic Load, and Daily Carbohydrates Intake with the Risk of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Long-Shan Yang, Lun-Jie Yan, Guang-Xiao Meng, Zi-Niu Ding, Sheng-Yu Yao, Hai-Chao Li, Zhao-Ru Dong, Zhi-Qiang Chen, Jian-Guo Hong, Tao Li
    Nutrition and Cancer.2023; 75(2): 461.     CrossRef
  • 4. Comprehensive Medical Evaluation and Assessment of Comorbidities:Standards of Care in Diabetes—2023
    Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Kenneth Cusi, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, Jose Leon, Sarah K. Lyons, Mary Lo
    Diabetes Care.2023; 46(Supplement): s49.     CrossRef
  • TCF7L2, CASC8, and GREM1 polymorphism and colorectal cancer in south-eastern Romanian population
    Anca Florentina Mitroi, Nicoleta Leopa, Eugen Dumitru, Andrei Dumitru, Cristina Tocia, Ioana Popescu, Adrian Mitroi, Răzvan Cătălin Popescu
    Medicine.2023; 102(7): e33056.     CrossRef
  • New benzimidazole‐oxadiazole derivatives: Synthesis, α‐glucosidase, α‐amylase activity, and molecular modeling studies as potential antidiabetic agents
    Ulviye Acar Çevik, Ismail Celik, Leyla Paşayeva, Hanifa Fatullayev, Hayrani E. Bostancı, Yusuf Özkay, Zafer A. Kaplancıklı
    Archiv der Pharmazie.2023;[Epub]     CrossRef
  • Synthesis, α-amylase and α-glucosidase inhibition and molecular docking studies of indazole derivatives
    Muhammad Nawaz, Muhammad Taha, Faiza Qureshi, Nisar Ullah, Manikandan Selvaraj, Sumaira Shahzad, Sridevi Chigurupati, Samar A. Abubshait, Tauqir Ahmad, Sampath Chinnam, Soleiman Hisaindee
    Journal of Biomolecular Structure and Dynamics.2022; 40(21): 10730.     CrossRef
  • Association between Alzheimer's disease and risk of cancer: A retrospective cohort study in Shanghai, China
    Ru‐Jing Ren, Qiang Huang, Gang Xu, Kai Gu, Eric B. Dammer, Chun‐Fang Wang, Xin‐Yi Xie, Wen Chen, Zhen‐Yi Shao, Sheng‐Di Chen, Gang Wang
    Alzheimer's & Dementia.2022; 18(5): 924.     CrossRef
  • 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2022

    Diabetes Care.2022; 45(Supplement): S46.     CrossRef
  • A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes‐Associated Breast Cancer
    Qiongyu Hao, Zhimin Huang, Qun Li, Dingxie Liu, Piwen Wang, Kun Wang, Jieqing Li, Wei Cao, Wenhong Deng, Ke Wu, Rui Su, Zhongmin Liu, Jay Vadgama, Yong Wu
    Advanced Science.2022;[Epub]     CrossRef
  • Seroreactivity Against Tyrosine Phosphatase PTPRN Links Type 2 Diabetes and Colorectal Cancer and Identifies a Potential Diagnostic and Therapeutic Target
    María Garranzo-Asensio, Guillermo Solís-Fernández, Ana Montero-Calle, José Manuel García-Martínez, Maria Carmen Fiuza, Pilar Pallares, Nuria Palacios-Garcia, Custodia García-Jiménez, Ana Guzman-Aranguez, Rodrigo Barderas
    Diabetes.2022; 71(3): 497.     CrossRef
  • Doxorubicin-induced apoptosis enhances monocyte infiltration and adverse cardiac remodeling in diabetic animals
    Chandrakala Aluganti Narasimhulu, Dinender K. Singla
    Canadian Journal of Physiology and Pharmacology.2022; 100(5): 441.     CrossRef
  • Sleep Disruption and Cancer: Chicken or the Egg?
    Adrian Berisha, Kyle Shutkind, Jeremy C. Borniger
    Frontiers in Neuroscience.2022;[Epub]     CrossRef
  • A comparative study of phytochemical, antioxidant, anticarcinogenic, and antidiabetic potential of coriander (Coriandrum sativum L.): Microgreen and mature plant
    G. M. Dhakshayani, S. Janaki Alias Priya
    Foods and Raw Materials.2022; : 283.     CrossRef
  • Influence of type II diabetes mellitus on postoperative complications following colorectal cancer surgery
    Răzvan Cătălin Popescu, Nicoleta Leopa, Eugen Dumitru, Anca Mitroi, Cristina Tocia, Andrei Dumitru, Costel Brînzan, Florin Botea
    Experimental and Therapeutic Medicine.2022;[Epub]     CrossRef
  • Diabetes Mellitus as a Risk Factor for Different Types of Cancers: A Systematic Review
    Saud S Alharbi
    Clinical Cancer Investigation Journal.2022; 11(4): 19.     CrossRef
  • Survival of Colorectal Cancer Patients With Diabetes Mellitus: A Meta-Analysis
    Fausto Petrelli, Michele Ghidini, Emanuele Rausa, Antonio Ghidini, Mary Cabiddu, Karen Borgonovo, Mara Ghilardi, Maria Chiara Parati, Filippo Pietrantonio, Paolo Sganzerla, Antonio Carlo Bossi
    Canadian Journal of Diabetes.2021; 45(2): 186.     CrossRef
  • 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2021

    Diabetes Care.2021; 44(Supplement): S40.     CrossRef
  • High glucose‐ROS conditions enhance the progression in cholangiocarcinoma via upregulation of MAN2A2 and CHD8
    Unchalee Thonsri, Sopit Wongkham, Chaisiri Wongkham, Shinjiro Hino, Mitsuyoshi Nakao, Sittiruk Roytrakul, Tomoaki Koga, Wunchana Seubwai
    Cancer Science.2021; 112(1): 254.     CrossRef
  • On the meaning of and relationship between dragon-kings, black swans and related concepts
    Ingrid Glette-Iversen, Terje Aven
    Reliability Engineering & System Safety.2021; 211: 107625.     CrossRef
  • Colonoscopy and Risk of Colorectal Cancer in Patients With Nonalcoholic Fatty Liver Disease: A Retrospective Territory‐Wide Cohort Study
    Xinrong Zhang, Vincent Wai‐Sun Wong, Terry Cheuk‐Fung Yip, Yee‐Kit Tse, Lilian Yan Liang, Vicki Wing‐Ki Hui, Guan‐Lin Li, Henry Lik‐Yuen Chan, Grace Lai‐Hung Wong
    Hepatology Communications.2021; 5(7): 1212.     CrossRef
  • Metabolic profiling analysis for clinical urine of colorectal cancer
    Wu Ning, Nan Qiao, Xiyin Zhang, Dongpo Pei, Wenyue Wang
    Asia-Pacific Journal of Clinical Oncology.2021; 17(4): 403.     CrossRef
  • Metformin suppresses breast cancer growth via inhibition of cyclooxygenase‑2
    Bin Shi, Xinyu Hu, Huimin He, Wenzheng Fang
    Oncology Letters.2021;[Epub]     CrossRef
  • Characteristics that influence the diagnosis and treatment of diabetes in geriatric patients over 75
    Angelo Scuteri
    Journal of Gerontology and Geriatrics.2021; 69(4): 238.     CrossRef
  • Need of integrated management of type ii diabetes mellitus as a serious risk factor in modifying outcomes in cancer management: A literature review
    YogeshNarayan Bendale, Vineeta Bendale, Pravin Gund, Avinash Kadam
    Indian Journal of Ayurveda and Integrative Medicine KLEU.2021; 2(2): 50.     CrossRef
  • Metformin use reduced the overall risk of cancer in diabetic patients: A study based on the Korean NHIS-HEALS cohort
    Ye-Seul Kim, Eun-A. Choi, Jae-woo Lee, Yonghwan Kim, Hyo-Sun You, Ye-Eun Han, Hyeong-Seop Kim, Yoon-Jong Bae, Hee-Taik Kang, Joungyoun Kim
    Nutrition, Metabolism and Cardiovascular Diseases.2020; 30(10): 1714.     CrossRef
  • No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression
    Jelle Evers, Anne J. Grotenhuis, Katja K. H. Aben, Lambertus A. L. M. Kiemeney, Alina Vrieling, Ernest K. Amankwah
    PLOS ONE.2020; 15(3): e0229384.     CrossRef
  • Prevalence of diabetes mellitus as well as cardiac and other main comorbidities in a representative sample of the adult Greek population in comparison with the general population
    Anastasios Tentolouris, Ioanna Eleftheriadou, Kostas Athanasakis, John Kyriopoulos, Diamantis I. Tsilimigras, Pinelopi Grigoropoulou, John Doupis, Nikolaos Tentolouris
    Hellenic Journal of Cardiology.2020; 61(1): 15.     CrossRef
  • A clinical prediction nomogram to assess risk of colorectal cancer among patients with type 2 diabetes
    Lu-Huai Feng, Tingting Su, Kun-Peng Bu, Shuang Ren, Zhenhua Yang, Cheng-En Deng, Bi-Xun Li, Wei-Yuan Wei
    Scientific Reports.2020;[Epub]     CrossRef
  • Cohort Profile: The Maule Cohort (MAUCO)
    Catterina Ferreccio, Andrea Huidobro, Sandra Cortés, Claudia Bambs, Pablo Toro, Vanessa Van De Wyngard, Johanna Acevedo, Fabio Paredes, Pía Venegas, Hugo Verdejo, Ximena Oyarzún-González, Paz Cook, Pablo F Castro, Claudia Foerster, Claudio Vargas, Jill Ko
    International Journal of Epidemiology.2020; 49(3): 760.     CrossRef
  • Gastric Cancer Heterogeneity and Clinical Outcomes
    Rachel E. Sexton, Mohammed Najeeb Al Hallak, Md. Hafiz Uddin, Maria Diab, Asfar S. Azmi
    Technology in Cancer Research & Treatment.2020; 19: 153303382093547.     CrossRef
  • Temporal trajectories of accompanying comorbidities in patients with type 2 diabetes: a Korean nationwide observational study
    Eugene Jeong, Namgi Park, Yujeong Kim, Ja Young Jeon, Wou Young Chung, Dukyong Yoon
    Scientific Reports.2020;[Epub]     CrossRef
  • Utility of KRAS Gene and Clinicopathological Features in the Assessment of the Risk of Type 2 Diabetes in the Etiology of Colon Cancer
    Wedad Saeed Al-Qahtani, Ebtesam Al-Olayan, Fatimah Gh. Albani, Rania Saad Suliman, Nada Hamad Aljarba, E.M. Al-Humaidhi, Alanood S. Almurshedi, Dalia Mostafa Domiaty, Manal Abdullah Alduwish, Aljohara M. Al-Otaibi, Abdelbaset Mohamed Elasbali, Hussain Gad
    Global Medical Genetics.2020; 07(02): 035.     CrossRef
  • Glycation Leads to Increased Polysialylation and Promotes the Metastatic Potential of Neuroblastoma Cells
    Maximilian Scheer, Kaya Bork, Frieder Simon, Manimozhi Nagasundaram, Rüdiger Horstkorte, Vinayaga Srinivasan Gnanapragassam
    Cells.2020; 9(4): 868.     CrossRef
  • Site-specific cancer risk in patients with type 2 diabetes: a nationwide population-based cohort study in Korea
    Suk Kyeong Kim, Ju-Young Jang, Dong-Lim Kim, Young A Rhyu, Suh Eun Lee, Seung-Hyun Ko, Kyungdo Han, Kee-Ho Song
    The Korean Journal of Internal Medicine.2020; 35(3): 641.     CrossRef
  • Synthesis, α-glucosidase inhibition and antioxidant activity of the 7-carbo–substituted 5-bromo-3-methylindazoles
    Malose J. Mphahlele, Nontokozo M. Magwaza, Samantha Gildenhuys, Itumeleng B. Setshedi
    Bioorganic Chemistry.2020; 97: 103702.     CrossRef
  • 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2020

    Diabetes Care.2020; 43(Supplement): S37.     CrossRef
  • 4. Comprehensive Medical Evaluation and Assessment of Comorbidities:Standards of Medical Care in Diabetes—2019

    Diabetes Care.2019; 42(Supplement): S34.     CrossRef
  • Diabetes‐mediated promotion of colon mucosa carcinogenesis is associated with mitochondrial dysfunction
    Laura Del Puerto‐Nevado, Aranzazu Santiago‐Hernandez, Sonia Solanes‐Casado, Nieves Gonzalez, Marta Ricote, Marta Corton, Isabel Prieto, Sebastian Mas, Ana Belen Sanz, Oscar Aguilera, Carmen Gomez‐Guerrero, Carmen Ayuso, Alberto Ortiz, Federico Rojo, Jesus
    Molecular Oncology.2019; 13(9): 1887.     CrossRef
  • Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment
    Sunghwan Suh, Kwang-Won Kim
    Diabetes & Metabolism Journal.2019; 43(6): 733.     CrossRef
  • Lorcaserin for prevention and remission of type 2 diabetes mellitus in people with overweight or obesity: protocol for a systematic review and meta-analysis
    Hai Zeng, Meng Luo, Zunjiang Li, Junru Wen, Guoxin He, Yuelin Jin, Wenbin Fu, Peng Zhou
    BMJ Open.2019; 9(7): e029426.     CrossRef
  • Disseminated Well-Differentiated Gastro-Entero-Pancreatic Tumors Are Associated with Metabolic Syndrome
    Santos, Castro, Antunes, Henrique, Cardoso, Monteiro
    Journal of Clinical Medicine.2019; 8(9): 1479.     CrossRef
  • Effects of Aspirin or Clopidogrel on Colorectal Cancer Chemoprevention in Patients with Type 2 Diabetes Mellitus
    Yi-Chun Kuan, Kuang-Wei Huang, Cheng-Li Lin, Jiing-Chyuan Luo, Chia-Hung Kao
    Cancers.2019; 11(10): 1468.     CrossRef
  • Retrospective database analysis of cancer risk in patients with type 2 diabetes mellitus in China
    Xiaoning He, Lizheng Shi, Jing Wu
    Current Medical Research and Opinion.2018; 34(6): 1089.     CrossRef
  • Association of genetic variants in ATR-CHEK1 and ATM-CHEK2 pathway genes with risk of colorectal cancer in a Chinese population
    Shijia Wang, Yue Zhang, Min Chen, Yong Wang, Yifei Feng, Ziwei Xu, Dongsheng Zhang, Yueming Sun, Zan Fu
    Oncotarget.2018; 9(42): 26616.     CrossRef
  • Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD)
    Prateek Sharma, Sanjeev Kumar
    Cellular Oncology.2018; 41(6): 637.     CrossRef
  • 3. Comprehensive Medical Evaluation and Assessment of Comorbidities:Standards of Medical Care in Diabetes—2018

    Diabetes Care.2018; 41(Supplement): S28.     CrossRef
  • 2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications
    Nieves González, Isabel Prieto, Laura del Puerto-Nevado, Sergio Portal-Nuñez, Juan Antonio Ardura, Marta Corton, Beatriz Fernández-Fernández, Oscar Aguilera, Carmen Gomez-Guerrero, Sebastián Mas, Juan Antonio Moreno, Marta Ruiz-Ortega, Ana Belen Sanz, Mar
    Oncotarget.2017; 8(11): 18456.     CrossRef
  • Systems and precision medicine approaches to diabetes heterogeneity: a Big Data perspective
    Enrico Capobianco
    Clinical and Translational Medicine.2017;[Epub]     CrossRef
  • Hyperglycemia exacerbates colon cancer malignancy through hexosamine biosynthetic pathway
    A Vasconcelos-dos-Santos, H F B R Loponte, N R Mantuano, I A Oliveira, I F de Paula, L K Teixeira, J C M de-Freitas-Junior, K C Gondim, N Heise, R Mohana-Borges, J A Morgado-Díaz, W B Dias, A R Todeschini
    Oncogenesis.2017; 6(3): e306.     CrossRef
  • A Comprehensive Survey of the Roles of Highly Disordered Proteins in Type 2 Diabetes
    Zhihua Du, Vladimir Uversky
    International Journal of Molecular Sciences.2017; 18(10): 2010.     CrossRef
  • Colon cancer modulation by a diabetic environment: A single institutional experience
    Isabel Prieto, Laura del Puerto-Nevado, Nieves Gonzalez, Sergio Portal-Nuñez, Sandra Zazo, Marta Corton, Pablo Minguez, Carmen Gomez-Guerrero, Jose Miguel Arce, Ana Belen Sanz, Sebastian Mas, Oscar Aguilera, Gloria Alvarez-Llamas, Pedro Esbrit, Alberto Or
    PLOS ONE.2017; 12(3): e0172300.     CrossRef
  • Prevalence of elevated liver enzymes in adults with type 1 diabetes: A multicentre analysis of the German/Austrian DPV database
    Marietta Stadler, Esther Bollow, Maria Fritsch, Wolfgang Kerner, Ingrid Schuetz‐Fuhrmann, Dietmar Krakow, Sigrun Merger, Michaela Riedl, Peter Jehle, Reinhard W. Holl
    Diabetes, Obesity and Metabolism.2017; 19(8): 1171.     CrossRef
  • Review of 2017 Diabetes Standards of Care
    Kate Crawford
    Nursing Clinics of North America.2017; 52(4): 621.     CrossRef
  • Glycans as Regulatory Elements of the Insulin/IGF System: Impact in Cancer Progression
    Julio de-Freitas-Junior, Jéssica Andrade-da-Costa, Mariana Silva, Salomé Pinho
    International Journal of Molecular Sciences.2017; 18(9): 1921.     CrossRef
  • 3. Comprehensive Medical Evaluation and Assessment of Comorbidities

    Diabetes Care.2017; 40(Supplement): S25.     CrossRef
  • Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells
    Hao Cai, Yunhui Zhang, Tianxiang Kevin Han, Ruth S. Everett, Dhiren R. Thakker
    International Journal of Cancer.2016; 138(9): 2281.     CrossRef
  • Looking at the carcinogenicity of human insulin analogues via the intrinsic disorder prism
    Elrashdy M. Redwan, Moustafa H. Linjawi, Vladimir N. Uversky
    Scientific Reports.2016;[Epub]     CrossRef
  • Two variants on T2DM susceptible gene HHEX are associated with CRC risk in a Chinese population
    Rui Sun, Jian-Ping Liu, Chang Gao, Ying-Ying Xiong, Min Li, Ya-Ping Wang, Yan-Wei Su, Mei Lin, An-Li Jiang, Ling-Fan Xiong, Yan Xie, Jue-Ping Feng
    Oncotarget.2016; 7(20): 29770.     CrossRef
  • 3. Foundations of Care and Comprehensive Medical Evaluation

    Diabetes Care.2016; 39(Supplement): S23.     CrossRef
  • Mortality and causes of death in a national sample of type 2 diabetic patients in Korea from 2002 to 2013
    Yu Mi Kang, Ye-Jee Kim, Joong-Yeol Park, Woo Je Lee, Chang Hee Jung
    Cardiovascular Diabetology.2016;[Epub]     CrossRef
  • Association Between Chronic Conditions and Physical Function Among Veteran and Non-Veteran Women With Diabetes
    Kristen E. Gray, Jodie G. Katon, Eileen Rillamas-Sun, Lori A. Bastian, Karin M. Nelson, Andrea Z. LaCroix, Gayle E. Reiber
    The Gerontologist.2016; 56(Suppl 1): S112.     CrossRef
  • 3. Initial Evaluation and Diabetes Management Planning

    Diabetes Care.2015; 38(Supplement): S17.     CrossRef
  • Lack of metformin effect on mouse embryo AMPK activity: implications for metformin treatment during pregnancy
    Hyung‐yul Lee, Dan Wei, Mary R. Loeken
    Diabetes/Metabolism Research and Reviews.2014; 30(1): 23.     CrossRef
  • Standards of Medical Care in Diabetes—2014

    Diabetes Care.2014; 37(Supplement): S14.     CrossRef
  • Detection bias may be the main cause of increased cancer incidence among diabetics: Results from the Rotterdam Study
    Kirstin M.J. De Bruijn, Rikje Ruiter, Catherine E. de Keyser, Albert Hofman, Bruno H. Stricker, Casper H.J. van Eijck
    European Journal of Cancer.2014; 50(14): 2449.     CrossRef
  • Effects of Metformin Dose on Cancer Risk Reduction in Patients with Type 2 Diabetes Mellitus: A 6-Year Follow-up Study
    Hsiu-Chen Lin, Baxter H. Kachingwe, Hsiu-Li Lin, Hui Wen Cheng, Yow-Shieng Uang, Li-Hsuan Wang
    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.2014; 34(1): 36.     CrossRef
  • Hyperglycemia as a Risk Factor for Cancer Progression
    Tae Young Ryu, Jiyoung Park, Philipp E. Scherer
    Diabetes & Metabolism Journal.2014; 38(5): 330.     CrossRef
  • High glucose and insulin differentially modulates proliferation in MCF-7 and MDA-MB-231 cells
    Chanchal Gupta, Kulbhushan Tikoo
    Journal of Molecular Endocrinology.2013; 51(1): 119.     CrossRef
  • Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer
    K M J De Bruijn, L R Arends, B E Hansen, S Leeflang, R Ruiter, C H J van Eijck
    British Journal of Surgery.2013; 100(11): 1421.     CrossRef
  • Obesity, diabetes mellitus, and the risk of female breast cancer in Eastern China
    Xiao-Lei Wang, Cun-Xian Jia, Li-Yuan Liu, Qiang Zhang, Yu-Yang Li, Liang Li
    World Journal of Surgical Oncology.2013;[Epub]     CrossRef
  • Effect of Type 2 Diabetes Mellitus on Prognosis of Nonmetastatic Renal Cell Cancer
    Evren Süer, Erdem Öztürk, Ömer Gülpınar, Aytaç Kayış, Sümer Baltacı
    Korean Journal of Urology.2013; 54(8): 499.     CrossRef
  • Glycemic index, glycemic load and cancer risk
    J. Hu, C. La Vecchia, L.S. Augustin, E. Negri, M. de Groh, H. Morrison, L. Mery
    Annals of Oncology.2013; 24(1): 245.     CrossRef
  • The Relationship between Type 2 Diabetes and Cancer: An Integrative Review
    Mutaz Arafat Altamimi
    SSRN Electronic Journal.2013;[Epub]     CrossRef
  • Diabetes Mellitus and the Risk for Developing Cancer
    Shane Malachy Markey, Marie A Congiusta
    International Journal of Experimental Dental Science.2013; 2(1): 41.     CrossRef
  • Standards of Medical Care in Diabetes—2013

    Diabetes Care.2013; 36(Supplement): S11.     CrossRef
  • Targeted therapy in rare cancers—adopting the orphans
    Javier Munoz, Razelle Kurzrock
    Nature Reviews Clinical Oncology.2012; 9(11): 631.     CrossRef
  • Obesity and Pancreatic Diseases
    Ho Gak Kim, Jimin Han
    The Korean Journal of Gastroenterology.2012; 59(1): 35.     CrossRef
  • CYP2W1, CYP4F11 and CYP8A1 Polymorphisms and Interaction of CYP2W1 Genotypes with Risk Factors in Mexican Women with Breast Cancer
    N. Cardenas-Rodriguez, E. Lara-Padilla, C. Bandala, J. Lopez-Cruz, C. Uscanga-Carmona, P.F. Lucio-Monter, E. Floriano-Sanchez
    Asian Pacific Journal of Cancer Prevention.2012; 13(3): 837.     CrossRef
  • Standards of Medical Care in Diabetes—2012

    Diabetes Care.2012; 35(Supplement): S11.     CrossRef
  • The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone
    Sun Ok Song, Kwang Joon Kim, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
    Diabetes & Metabolism Journal.2012; 36(5): 371.     CrossRef
  • L’uso prolungato di metformina è associato con la riduzione del rischio di carcinoma mammario
    M. Bodmer, C. Meier, S. Krähenbühl, S. S. Jick, C. R. Meier, Francesca Marciello, Antongiulio Faggiano, Annamaria Colao
    L'Endocrinologo.2011; 12(6): 310.     CrossRef
Clinical Allogeneic and Autologous Islet Cell Transplantation: Update
Shinichi Matsumoto
Diabetes Metab J. 2011;35(3):199-206.   Published online June 30, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.3.199
  • 10,955 View
  • 43 Download
  • 17 Crossref
AbstractAbstract PDFPubReader   

Islet cell transplantation is categorized as a β-cell replacement therapy for diabetic patients who lack the ability to secrete insulin. Allogeneic islet cell transplantation is for the treatment of type 1 diabetes, and autologous islet cell transplantation is for the prevention of surgical diabetes after a total pancreatectomy. The issues of allogeneic islet cell transplantation include poor efficacy of islet isolation, the need for multiple donor pancreata, difficulty maintaining insulin independence and undesirable side effects of immunosuppressive drugs. Those issues have been solved step by step and allogeneic islet cell transplantation is almost ready to be the standard therapy. The donor shortage will be the next issue and marginal and/or living donor islet cell transplantation might alleviate the issue. Xeno-islet cell transplantation, β-cell regeneration from human stem cells and gene induction of the naïve pancreas represent the next generation of β-cell replacement therapy. Autologous islet cell transplantation after total pancreatectomy for the treatment of chronic pancreatitis with severe abdominal pain is the standard therapy, even though only limited centers are able to perform this treatment. Remote center autologous islet cell transplantation is an attractive option for hospitals performing total pancreatectomies without the proper islet isolation facilities.

Citations

Citations to this article as recorded by  
  • Immunoprotection of cellular transplants for autoimmune type 1 diabetes through local drug delivery
    T.R. Lansberry, C.L. Stabler
    Advanced Drug Delivery Reviews.2024; 206: 115179.     CrossRef
  • Efficacy and safety of total pancreatectomy with islet autotransplantation: A clinical study in Japan
    Masayuki Shimoda, Daisuke Chujo, Toshiaki Kurokawa, Akitsu Kawabe, Nobuyuki Takahashi, Kyoji Ito, Koji Maruyama, Koya Shinohara, Kumiko Ajima, Yzumi Sugahara, Tadashi Takaki, Hiroshi Kajio, Mikio Yanase, Chihaya Hinohara, Makoto Tokuhara, Yukari Uemura, Y
    Journal of Diabetes.2021; 13(11): 940.     CrossRef
  • Islet cell transplantation in children
    Appakalai N. Balamurugan, Deborah A. Elder, Maisam Abu-El-Haija, Jaimie D. Nathan
    Seminars in Pediatric Surgery.2020; 29(3): 150925.     CrossRef
  • Establishment of a diabetes mellitus type 1 model in the common marmoset
    Wenji Yuan, Satsuki Fukuda, Takashi Inoue, Hitoshi Okochi, Erika Sasaki, Masayuki Shimoda
    Scientific Reports.2019;[Epub]     CrossRef
  • Tolerogenic Dendritic Cells and T-Regulatory Cells at the Clinical Trials Crossroad for the Treatment of Autoimmune Disease; Emphasis on Type 1 Diabetes Therapy
    Brett Eugene Phillips, Yesica Garciafigueroa, Carl Engman, Massimo Trucco, Nick Giannoukakis
    Frontiers in Immunology.2019;[Epub]     CrossRef
  • Is islet transplantation a realistic approach to curing diabetes?
    Sang-Man Jin, Kwang-Won Kim
    The Korean Journal of Internal Medicine.2017; 32(1): 62.     CrossRef
  • Single Cell Microgel Based Modular Bioinks for Uncoupled Cellular Micro‐ and Macroenvironments
    Tom Kamperman, Sieger Henke, Albert van den Berg, Su Ryon Shin, Ali Tamayol, Ali Khademhosseini, Marcel Karperien, Jeroen Leijten
    Advanced Healthcare Materials.2017;[Epub]     CrossRef
  • Long-term Efficacy and Biocompatibility of Encapsulated Islet Transplantation With Chitosan-Coated Alginate Capsules in Mice and Canine Models of Diabetes
    Hae Kyung Yang, Dong-Sik Ham, Heon-Seok Park, Marie Rhee, Young Hye You, Min Jung Kim, Juyoung Shin, On-You Kim, Gilson Khang, Tae Ho Hong, Ji-Won Kim, Seung-Hwan Lee, Jae-Hyoung Cho, Kun-Ho Yoon
    Transplantation.2016; 100(2): 334.     CrossRef
  • Senp2 expression was induced by chronic glucose stimulation in INS1 cells, and it was required for the associated induction of Ccnd1 and Mafa
    Hye Seung Jung, Yu Mi Kang, Ho Seon Park, Byung Yong Ahn, Hakmo Lee, Min Joo Kim, Jin Young Jang, Sun-Whe Kim
    Islets.2016; 8(6): 207.     CrossRef
  • Islet autotransplantation: past, present and future. Chapter II: the role of islet autotransplantation for the treatment of chronic pancreatitis
    Elina Linetsky, Muyesser Sayki Arslan, Rodolfo Alejandro, Camillo Ricordi
    Diabetes Management.2015; 5(2): 103.     CrossRef
  • Feasibility of islet magnetic resonance imaging using ferumoxytol in intraportal islet transplantation
    Sang-Man Jin, Seung-Hoon Oh, Bae Jun Oh, Wooyoung Shim, Jin Myung Choi, Dongkyeom Yoo, Yong Hwa Hwang, Jung Hee Lee, Dong Yun Lee, Jae Hyeon Kim
    Biomaterials.2015; 52: 272.     CrossRef
  • Cell aggregation optimizes the differentiation of human ESCs and iPSCs into pancreatic bud-like progenitor cells
    Taro Toyoda, Shin-Ichi Mae, Hiromi Tanaka, Yasushi Kondo, Michinori Funato, Yoshiya Hosokawa, Tomomi Sudo, Yoshiya Kawaguchi, Kenji Osafune
    Stem Cell Research.2015; 14(2): 185.     CrossRef
  • Improved Insulin Secretion by Autologous Islet Transplantation, Compared to Oral Antidiabetic Agents, after Distal Pancreatectomy
    Ji Won Yoon, Hye Seung Jung, Jin Young Jang, Min Joo Kim, Jung Hee Kim, Jung Hun Ohn, Jae Hyeon Kim, Hak Mo Lee, Hyo Cheol Kim, Kyoung Bun Lee, Seung A Choi, Sun-Whe Kim, Kyong Soo Park
    Cell Transplantation.2015; 24(8): 1615.     CrossRef
  • The Potential of Endothelial Colony-Forming Cells to Improve Early Graft Loss after Intraportal Islet Transplantation
    Hye Seung Jung, Min Joo Kim, Shin Hee Hong, Ye Jin Lee, Shiane Kang, Hakmo Lee, Sung Soo Chung, Joong Shin Park, Kyong Soo Park
    Cell Transplantation.2014; 23(3): 273.     CrossRef
  • Pancreatic islet autotransplantation with total pancreatectomy for chronic pancreatitis
    Tamotsu Kuroki, Tomohiko Adachi, Shinichiro Ono, Takayuki Tanaka, Amane Kitasato, Susumu Eguchi
    Surgery Today.2013; 43(7): 715.     CrossRef
  • Pre-culturing islets with mesenchymal stromal cells using a direct contact configuration is beneficial for transplantation outcome in diabetic mice
    Chloe Louise Rackham, Paramjeet Kaur Dhadda, Pedro Cesar Chagastelles, Sian Jazmine Shakara Simpson, Anshi Anjili Dattani, James Edward Bowe, Peter Martin Jones, Aileen Jean Fiona King
    Cytotherapy.2013; 15(4): 449.     CrossRef
  • A Scalable System for Production of Functional Pancreatic Progenitors from Human Embryonic Stem Cells
    Thomas C. Schulz, Holly Y. Young, Alan D. Agulnick, M. Josephine Babin, Emmanuel E. Baetge, Anne G. Bang, Anindita Bhoumik, Igor Cepa, Rosemary M. Cesario, Carl Haakmeester, Kuniko Kadoya, Jonathan R. Kelly, Justin Kerr, Laura A. Martinson, Amanda B. McLe
    PLoS ONE.2012; 7(5): e37004.     CrossRef
Sulwon Lecture 2010
Mitochondrial Dysfunction and Insulin Resistance: The Contribution of Dioxin-Like Substances
Hong Kyu Lee
Diabetes Metab J. 2011;35(3):207-215.   Published online June 30, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.3.207
  • 45,458 View
  • 39 Download
  • 21 Crossref
AbstractAbstract PDFPubReader   

Persistent organic pollutants (POPs) are known to cause mitochondrial dysfunction and this in turn is linked to insulin resistance, a key biochemical abnormality underlying the metabolic syndrome. To establish the cause and effect relationship between exposure to POPs and the development of the metabolic syndrome, Koch's postulates were considered. Problems arising from this approach were discussed and possible solutions were suggested. In particular, the difficulty of establishing a cause and effect relationship due to the vagueness of the metabolic syndrome as a disease entity was discussed. Recently a bioassay, aryl-hydrocarbon receptor (AhR) trans-activation activity using a cell line expressing AhR-luciferase, showed that its activity is linearly related with the parameters of the metabolic syndrome in a population. This finding suggests the possible role of bioassays in the analysis of multiple pollutants of similar kinds in the pathogenesis of several closely related diseases, such as type 2 diabetes and the metabolic syndrome. Understanding the effects of POPs on mitochondrial function will be very useful in understanding the integration of various factors involved in this process, such as genes, fetal malnutrition and environmental toxins and their protectors, as mitochondria act as a unit according to the metabolic scaling law.

Citations

Citations to this article as recorded by  
  • Drug-induced mitochondrial toxicity: Risks of developing glucose handling impairments
    Auxiliare Kuretu, Charles Arineitwe, Mamosheledi Mothibe, Phikelelani Ngubane, Andile Khathi, Ntethelelo Sibiya
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Obesogens in Foods
    Iva Kladnicka, Monika Bludovska, Iveta Plavinova, Ludek Muller, Dana Mullerova
    Biomolecules.2022; 12(5): 680.     CrossRef
  • Pesticides and pancreatic adenocarcinoma: A transversal epidemiological, environmental and mechanistic narrative review
    Mathias Brugel, Claire Carlier, Gabriela Reyes-Castellanos, Sidonie Callon, Alice Carrier, Olivier Bouché
    Digestive and Liver Disease.2022; 54(12): 1605.     CrossRef
  • Low-Dose Dioxin Reduced Glucose Uptake in C2C12 Myocytes: The Role of Mitochondrial Oxidative Stress and Insulin-Dependent Calcium Mobilization
    Suyeol Im, Sora Kang, Ji Hwan Kim, Seung Jun Oh, Youngmi Kim Pak
    Antioxidants.2022; 11(11): 2109.     CrossRef
  • Hallmarks of Health
    Carlos López-Otín, Guido Kroemer
    Cell.2021; 184(1): 33.     CrossRef
  • Prenatal exposure to persistent organic pollutants and markers of obesity and cardiometabolic risk in Spanish adolescents
    Nuria Güil-Oumrait, Damaskini Valvi, Raquel Garcia-Esteban, Monica Guxens, Jordi Sunyer, Maties Torrent, Maribel Casas, Martine Vrijheid
    Environment International.2021; 151: 106469.     CrossRef
  • Clinical Value of Serum Mitochondria-Inhibiting Substances in Assessing Renal Hazards: A Community-Based Prospective Study in Korea
    Hoon Sung Choi, Jin Taek Kim, Hong Kyu Lee, Wook Ha Park, Youngmi Kim Pak, Sung Woo Lee
    Endocrinology and Metabolism.2021; 36(6): 1298.     CrossRef
  • Potential role of aryl hydrocarbon receptor signaling in childhood obesity
    Nancy N. Shahin, Ghada T. Abd-Elwahab, Afaf A. Tawfiq, Hanan M. Abdelgawad
    Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.2020; 1865(8): 158714.     CrossRef
  • Potential contribution of insecticide exposure and development of obesity and type 2 diabetes
    Xiao Xiao, John M. Clark, Yeonhwa Park
    Food and Chemical Toxicology.2017; 105: 456.     CrossRef
  • Persistent Organic Pollutants as Risk Factors for Obesity and Diabetes
    Chunxue Yang, Alice Pik Shan Kong, Zongwei Cai, Arthur C.K. Chung
    Current Diabetes Reports.2017;[Epub]     CrossRef
  • Aryl hydrocarbon receptor deficiency protects mice from diet-induced adiposity and metabolic disorders through increased energy expenditure
    C-X Xu, C Wang, Z-M Zhang, C D Jaeger, S L Krager, K M Bottum, J Liu, D-F Liao, S A Tischkau
    International Journal of Obesity.2015; 39(8): 1300.     CrossRef
  • Disruption of Ah Receptor Signaling during Mouse Development Leads to Abnormal Cardiac Structure and Function in the Adult
    Vinicius S. Carreira, Yunxia Fan, Hisaka Kurita, Qin Wang, Chia-I Ko, Mindi Naticchioni, Min Jiang, Sheryl Koch, Xiang Zhang, Jacek Biesiada, Mario Medvedovic, Ying Xia, Jack Rubinstein, Alvaro Puga, Diego Fraidenraich
    PLOS ONE.2015; 10(11): e0142440.     CrossRef
  • Persistent organic pollutants and biomarkers of diabetes risk in a cohort of Great Lakes sport caught fish consumers
    Mary Turyk, Giamila Fantuzzi, Victoria Persky, Sally Freels, Anissa Lambertino, Maria Pini, Davina H. Rhodes, Henry A. Anderson
    Environmental Research.2015; 140: 335.     CrossRef
  • Serum aryl hydrocarbon receptor ligand activity is associated with insulin resistance and resulting type 2 diabetes
    Eun Roh, Soo Heon Kwak, Hye Seung Jung, Young Min Cho, Youngmi Kim Pak, Kyong Soo Park, Seong Yeon Kim, Hong Kyu Lee
    Acta Diabetologica.2015; 52(3): 489.     CrossRef
  • A cross-sectional analysis of dioxins and health effects in municipal and private waste incinerator workers in Japan
    Kenya YAMAMOTO, Mitsuhiro KUDO, Heihachiro ARITO, Yasutaka OGAWA, Tsutomu TAKATA
    INDUSTRIAL HEALTH.2015; 53(5): 465.     CrossRef
  • Association of Dioxin and Other Persistent Organic Pollutants (POPs) with Diabetes: Epidemiological Evidence and New Mechanisms of Beta Cell Dysfunction
    Vincenzo De Tata
    International Journal of Molecular Sciences.2014; 15(5): 7787.     CrossRef
  • The Glycated Albumin to Glycated Hemoglobin Ratio Might Not Be Associated with Carotid Atherosclerosis in Patients with Type 1 Diabetes
    Wonjin Kim, Kwang Joon Kim, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
    Diabetes & Metabolism Journal.2014; 38(6): 456.     CrossRef
  • Pesticides and human chronic diseases: Evidences, mechanisms, and perspectives
    Sara Mostafalou, Mohammad Abdollahi
    Toxicology and Applied Pharmacology.2013; 268(2): 157.     CrossRef
  • Coenzyme Q10 Ameliorates Pain and Cartilage Degradation in a Rat Model of Osteoarthritis by Regulating Nitric Oxide and Inflammatory Cytokines
    Jennifer Lee, Yeon Sik Hong, Jeong Hee Jeong, Eun Ji Yang, Joo Yeon Jhun, Mi Kyoung Park, Young Ok Jung, Jun Ki Min, Ho Youn Kim, Sung Hwan Park, Mi-La Cho, Zoltan Rakonczay
    PLoS ONE.2013; 8(7): e69362.     CrossRef
  • Plasmatic concentration of organochlorine lindane acts as metabolic disruptors in HepG2 liver cell line by inducing mitochondrial disorder
    Mohammed el Amine Benarbia, David Macherel, Sébastien Faure, Caroline Jacques, Ramaroson Andriantsitohaina, Yves Malthièry
    Toxicology and Applied Pharmacology.2013; 272(2): 325.     CrossRef
  • Increased Susceptibility to Metabolic Syndrome in Adult Offspring of Angiotensin Type 1 Receptor Autoantibody-Positive Rats
    Suli Zhang, Xi Zhang, Lihong Yang, Zi Yan, Li Yan, Jue Tian, Xiaoyu Li, Li Song, Li Wang, Xiaoli Yang, Ronghua Zheng, Wayne Bond Lau, Xinliang Ma, Huirong Liu
    Antioxidants & Redox Signaling.2012; 17(5): 733.     CrossRef
Editorial
Chemerin: A Novel Link between Inflammation and Atherosclerosis?
Eun-Jung Rhee
Diabetes Metab J. 2011;35(3):216-218.   Published online June 30, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.3.216
  • 2,701 View
  • 27 Download
  • 8 Crossref
PDFPubReader   

Citations

Citations to this article as recorded by  
  • Nutritional Status and Selected Adipokines in Children with Irritable Bowel Syndrome
    Wojciech Roczniak, Agnieszka Szymlak, Bogdan Mazur, Agata Chobot, Małgorzata Stojewska, Joanna Oświęcimska
    Nutrients.2022; 14(24): 5282.     CrossRef
  • Chemerin regulates formation and function of brown adipose tissue: Ablation results in increased insulin resistance with high fat challenge and aging
    Yiqiang Zhang, Wen‐Jun Shen, Shuo Qiu, Pinglin Yang, Garrett Dempsey, Lei Zhao, Qin Zhou, Xiao Hao, Dachuan Dong, Andreas Stahl, Fredric B. Kraemer, Lawrence L. Leung, John Morser
    The FASEB Journal.2021;[Epub]     CrossRef
  • Chemerin predicts carotid intima‐media thickening in severe obesity
    Stefano Ministrini, Maria Anastasia Ricci, Elisa Nulli Migliola, Stefano De Vuono, Marco D’Abbondanza, Maria Teresa Paganelli, Gaetano Vaudo, Donatella Siepi, Graziana Lupattelli
    European Journal of Clinical Investigation.2020;[Epub]     CrossRef
  • Chemerin promotes angiogenesis in vivo
    Nobuhisa Nakamura, Keiko Naruse, Yasuko Kobayashi, Megumi Miyabe, Tomokazu Saiki, Atsushi Enomoto, Masahide Takahashi, Tatsuaki Matsubara
    Physiological Reports.2018; 6(24): e13962.     CrossRef
  • International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) Nomenclature, Pharmacology, and Function
    Amanda J. Kennedy, Anthony P. Davenport, Eliot H. Ohlstein
    Pharmacological Reviews.2018; 70(1): 174.     CrossRef
  • Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia
    Viktória E. Varga, Hajnalka Lőrincz, Noémi Zsíros, Péter Fülöp, Ildikó Seres, György Paragh, József Balla, Mariann Harangi
    Lipids in Health and Disease.2016;[Epub]     CrossRef
  • Evaluation of plasma chemerin levels in patients with non-dipper blood pressure patterns
    Adem Uzun
    Medical Science Monitor.2014; 20: 698.     CrossRef
  • Serum chemerin levels during normal human pregnancy
    Maria F. Garces, Elizabeth Sanchez, Ariel I. Ruíz-Parra, Jorge Andrés Rubio-Romero, Edith Angel-Müller, Miguel A. Suarez, Luisa F. Bohórquez, Susana B. Bravo, Rubén Nogueiras, Carlos Diéguez, Jorge E. Caminos
    Peptides.2013; 42: 138.     CrossRef
Original Articles
ATP-Sensitive Potassium Channel-Deficient Mice Show Hyperphagia but Are Resistant to Obesity
Yeul Bum Park, Yun Jung Choi, So Young Park, Jong Yeon Kim, Seong Ho Kim, Dae Kyu Song, Kyu Chang Won, Yong Woon Kim
Diabetes Metab J. 2011;35(3):219-225.   Published online June 30, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.3.219
  • 3,537 View
  • 31 Download
  • 14 Crossref
AbstractAbstract PDFPubReader   
Background

The hypothalamus, the center for body weight regulation, can sense changes in blood glucose level based on ATP-sensitive potassium (KATP) channels in the hypothalamic neurons. We hypothesized that a lack of glucose sensing in the hypothalamus affects the regulations of appetite and body weight.

Methods

To evaluate this hypothesis, the responses to glucose loading and high fat feeding for eight weeks were compared in Kir6.2 knock-out (KO) mice and control C57BL/6 mice, because Kir6.2 is a key component of the KATP channel.

Results

The hypothalamic neuropeptide Y (NPY) analyzed one hour after glucose injection was suppressed in C57BL/6 mice, but not in Kir6.2 KO mice, suggesting a blunted hypothalamic response to glucose in Kir6.2 KO mice. The hypothalamic NPY expression at a fed state was elevated in Kir6.2 KO mice and was accompanied with hyperphagia. However, the retroperitoneal fat mass was markedly decreased in Kir6.2 KO mice compared to that in C57BL/6 mice. Moreover, the body weight and visceral fat following eight weeks of high fat feeding in Kir6.2 KO mice were not significantly different from those in control diet-fed Kir6.2 KO mice, while body weight and visceral fat mass were elevated due to high fat feeding in C57BL/6 mice.

Conclusion

These results suggested that Kir6.2 KO mice showed a blunted hypothalamic response to glucose loading and elevated hypothalamic NPY expression accompanied with hyperphagia, while visceral fat mass was decreased, suggesting resistance to diet-induced obesity. Further study is needed to explain this phenomenon.

Citations

Citations to this article as recorded by  
  • 17β-estradiol promotes acute refeeding in hungry mice via membrane-initiated ERα signaling
    Kaifan Yu, Yanlin He, Ilirjana Hyseni, Zhou Pei, Yongjie Yang, Pingwen Xu, Xing Cai, Hesong Liu, Na Qu, Hailan Liu, Yang He, Meng Yu, Chen Liang, Tingting Yang, Julia Wang, Pierre Gourdy, Jean-Francois Arnal, Francoise Lenfant, Yong Xu, Chunmei Wang
    Molecular Metabolism.2020; 42: 101053.     CrossRef
  • Brain Glucose-Sensing Mechanism and Energy Homeostasis
    A. J. López-Gambero, F. Martínez, K. Salazar, M. Cifuentes, F. Nualart
    Molecular Neurobiology.2019; 56(2): 769.     CrossRef
  • The involvement of purinergic signalling in obesity
    Geoffrey Burnstock, Daniela Gentile
    Purinergic Signalling.2018; 14(2): 97.     CrossRef
  • High‐fat‐diet‐induced remission of diabetes in a subset of KATP‐GOF insulin‐secretory‐deficient mice
    Zihan Yan, Zeenat A. Shyr, Manuela Fortunato, Alecia Welscher, Mariana Alisio, Michael Martino, Brian N. Finck, Hannah Conway, Maria S. Remedi
    Diabetes, Obesity and Metabolism.2018; 20(11): 2574.     CrossRef
  • Hypothalamic arcuate nucleus glucokinase regulates insulin secretion and glucose homeostasis
    Yue Ma, Risheka Ratnasabapathy, Chioma Izzi‐Engbeaya, Marie‐Sophie Nguyen‐Tu, Errol Richardson, Sufyan Hussain, Ivan De Backer, Christopher Holton, Mariana Norton, Gaelle Carrat, Blanche Schwappach, Guy A. Rutter, Waljit S. Dhillo, James Gardiner
    Diabetes, Obesity and Metabolism.2018; 20(9): 2246.     CrossRef
  • Overexpression of WNK1 in POMC-expressing neurons reduces weigh gain via WNK4-mediated degradation of Kir6.2
    Woo Young Chung, Jung Woo Han, Woon Heo, Min Goo Lee, Joo Young Kim
    Molecular and Cellular Biochemistry.2018; 447(1-2): 165.     CrossRef
  • Insights into the role of neuronal glucokinase
    Ivan De Backer, Sufyan S. Hussain, Stephen R. Bloom, James V. Gardiner
    American Journal of Physiology-Endocrinology and Metabolism.2016; 311(1): E42.     CrossRef
  • Obesogenic and Diabetogenic Effects of High-Calorie Nutrition Require Adipocyte BK Channels
    Julia Illison, Lijun Tian, Heather McClafferty, Martin Werno, Luke H. Chamberlain, Veronika Leiss, Antonia Sassmann, Stefan Offermanns, Peter Ruth, Michael J. Shipston, Robert Lukowski
    Diabetes.2016; 65(12): 3621.     CrossRef
  • ABCC8 R1420H Loss-of-Function Variant in a Southwest American Indian Community: Association With Increased Birth Weight and Doubled Risk of Type 2 Diabetes
    Leslie J. Baier, Yunhua Li Muller, Maria Sara Remedi, Michael Traurig, Paolo Piaggi, Gregory Wiessner, Ke Huang, Alyssa Stacy, Sayuko Kobes, Jonathan Krakoff, Peter H. Bennett, Robert G. Nelson, William C. Knowler, Robert L. Hanson, Colin G. Nichols, Clif
    Diabetes.2015; 64(12): 4322.     CrossRef
  • Glucokinase activity in the arcuate nucleus regulates glucose intake
    Syed Hussain, Errol Richardson, Yue Ma, Christopher Holton, Ivan De Backer, Niki Buckley, Waljit Dhillo, Gavin Bewick, Shuai Zhang, David Carling, Steve Bloom, James Gardiner
    Journal of Clinical Investigation.2015; 125(1): 337.     CrossRef
  • Dissecting the Etiology of Type 2 Diabetes in the Pima Indian Population
    Ewan R. Pearson
    Diabetes.2015; 64(12): 3993.     CrossRef
  • Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems
    Uttio Roy Chowdhury, Cindy K. Bahler, Bradley H. Holman, Peter I. Dosa, Michael P. Fautsch, Ted S Acott
    PLOS ONE.2015; 10(11): e0141783.     CrossRef
  • Differential gene expression pattern in hypothalamus of chickens during fasting-induced metabolic reprogramming: Functions of glucose and lipid metabolism in the feed intake of chickens
    Xin-Ling Fang, Xiao-Tong Zhu, Sheng-Feng Chen, Zhi-Qi Zhang, Qing-Jie Zeng, Lin Deng, Jian-Long Peng, Jian-Jian Yu, Li-Na Wang, Song-Bo Wang, Ping Gao, Qing-Yan Jiang, Gang Shu
    Poultry Science.2014; 93(11): 2841.     CrossRef
  • Combined Treatment of Betulinic Acid, a PTP1B Inhibitor, with Orthosiphon stamineus Extract Decreases Body Weight in High-Fat–Fed Mice
    Yoon-Jung Choi, So-Young Park, Jong-Yeon Kim, Kyu-Chang Won, Bo-Ra Kim, Jong-Keun Son, Seung-Ho Lee, Yong-Woon Kim
    Journal of Medicinal Food.2013; 16(1): 2.     CrossRef
Comparison of EGF with VEGF Non-Viral Gene Therapy for Cutaneous Wound Healing of Streptozotocin Diabetic Mice
Junghae Ko, Haejung Jun, Hyesook Chung, Changshin Yoon, Taekyoon Kim, Minjeong Kwon, Soonhee Lee, Soojin Jung, Mikyung Kim, Jeong Hyun Park
Diabetes Metab J. 2011;35(3):226-235.   Published online June 30, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.3.226
  • 4,386 View
  • 34 Download
  • 20 Crossref
AbstractAbstract PDFPubReader   
Background

To accelerate the healing of diabetic wounds, various kinds of growth factors have been employed. It is the short half-life of administered growth factors in hostile wound beds that have limited wide-spread clinical usage. To overcome this limitation, growth factor gene therapy could be an attractive alternative rather than direct application of factors onto the wound beds. We administered two growth factor DNAs, epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF) into a cutaneous wound on diabetic mice. We compared the different characteristics of the healing wounds.

Methods

Streptozotocin was injected intraperitoneally to induce diabetes into C57BL/6J mice. The ultrasound micro-bubble destruction method with SonoVue as a bubbling agent was used for non-viral gene delivery of EGF828 and VEGF165 DNAs. Each gene was modified for increasing efficacy as FRM-EGF828 or minicircle VEGF165. The degree of neoangiogenesis was assessed using qualitative laser Doppler flowmetry. We compared wound size and histological findings of the skin wounds in each group.

Results

In both groups, accelerated wound closure was observed in the mice receiving gene therapy compared with non treated diabetic control mice. Blood flow detected by laser doppler flowmetry was better in the VEGF group than in the EGF group. Wound healing rates and histological findings were more accelerated in the EGF gene therapy group than the VEGF group, but were not statistically significant.

Conclusion

Both non-viral EGF and VEGF gene therapy administrations could improve the speed and quality of skin wound healing. However, the detailed histological characteristics of the healing wounds were different.

Citations

Citations to this article as recorded by  
  • Gene therapy to enhance angiogenesis in chronic wounds
    Elnaz Shaabani, Maryam Sharifiaghdam, Reza Faridi-Majidi, Stefaan C. De Smedt, Kevin Braeckmans, Juan C. Fraire
    Molecular Therapy - Nucleic Acids.2022; 29: 871.     CrossRef
  • Approaches to Modulate the Chronic Wound Environment Using Localized Nucleic Acid Delivery
    Adam G. Berger, Jonathan J. Chou, Paula T. Hammond
    Advances in Wound Care.2021; 10(9): 503.     CrossRef
  • Limited Treatment Options for Diabetic Wounds: Barriers to Clinical Translation Despite Therapeutic Success in Murine Models
    May Barakat, Luisa A. DiPietro, Lin Chen
    Advances in Wound Care.2021; 10(8): 436.     CrossRef
  • Minicircle‐based expression of vascular endothelial growth factor in mesenchymal stromal cells from diverse human tissues
    Joana Serra, Cláudia P. A. Alves, Joaquim M. S. Cabral, Gabriel A. Monteiro, Cláudia L. da Silva, Duarte Miguel F. Prazeres
    The Journal of Gene Medicine.2021;[Epub]     CrossRef
  • Mathematical Model Predicts that Acceleration of Diabetic Wound Healing is Dependent on Spatial Distribution of VEGF-A mRNA (AZD8601)
    S. Michaela Rikard, Paul J. Myers, Joachim Almquist, Peter Gennemark, Anthony C. Bruce, Maria Wågberg, Regina Fritsche-Danielson, Kenny M. Hansson, Matthew J. Lazzara, Shayn M. Peirce
    Cellular and Molecular Bioengineering.2021; 14(4): 321.     CrossRef
  • β-Neoendorphin Enhances Wound Healing by Promoting Cell Migration in Keratinocyte
    Dong Joo Yang, Sang Hyun Moh, Yun-Hee Choi, Ki Woo Kim
    Molecules.2020; 25(20): 4640.     CrossRef
  • Orf Virus IL-10 and VEGF-E Act Synergistically to Enhance Healing of Cutaneous Wounds in Mice
    Lyn M. Wise, Gabriella S. Stuart, Nicola C. Jones, Stephen B. Fleming, Andrew A. Mercer
    Journal of Clinical Medicine.2020; 9(4): 1085.     CrossRef
  • Engineering of Human Mesenchymal Stem/Stromal Cells with Vascular Endothelial Growth Factor–Encoding Minicircles for Angiogenic Ex Vivo Gene Therapy
    Joana Serra, Cláudia P.A. Alves, Liliana Brito, Gabriel A. Monteiro, Joaquim M.S. Cabral, Duarte Miguel F. Prazeres, Cláudia L. da Silva
    Human Gene Therapy.2019; 30(3): 316.     CrossRef
  • Therapeutic strategies for enhancing angiogenesis in wound healing
    Austin P. Veith, Kayla Henderson, Adrianne Spencer, Andrew D. Sligar, Aaron B. Baker
    Advanced Drug Delivery Reviews.2019; 146: 97.     CrossRef
  • Nanomedicines and gene therapy for the delivery of growth factors to improve perfusion and oxygenation in wound healing
    Céline M. Desmet, Véronique Préat, Bernard Gallez
    Advanced Drug Delivery Reviews.2018; 129: 262.     CrossRef
  • Electrospun Fibers as a Dressing Material for Drug and Biological Agent Delivery in Wound Healing Applications
    Mulugeta Gizaw, Jeffrey Thompson, Addison Faglie, Shih-Yu Lee, Pierre Neuenschwander, Shih-Feng Chou
    Bioengineering.2018; 5(1): 9.     CrossRef
  • Non-viral gene therapy: Gains and challenges of non-invasive administration methods
    Marianna Foldvari, Ding Wen Chen, Nafiseh Nafissi, Daniella Calderon, Lokesh Narsineni, Amirreza Rafiee
    Journal of Controlled Release.2016; 240: 165.     CrossRef
  • RETRACTED ARTICLE: Decellularized scaffolds containing hyaluronic acid and EGF for promoting the recovery of skin wounds
    Zhengzheng Wu, Yan Tang, Hongdou Fang, Zhongchun Su, Bin Xu, Yongliang Lin, Peng Zhang, Xing Wei
    Journal of Materials Science: Materials in Medicine.2015;[Epub]     CrossRef
  • Acute and chronic wound fluids inversely influence adipose‐derived stem cell function: molecular insights into impaired wound healing
    Paola Koenen, Timo A Spanholtz, Marc Maegele, Ewa Stürmer, Thomas Brockamp, Edmund Neugebauer, Oliver C Thamm
    International Wound Journal.2015; 12(1): 10.     CrossRef
  • Adipose‐derived stem cells and keratinocytes in a chronic wound cell culture model: the role of hydroxyectoine
    Oliver C Thamm, Panagiotis Theodorou, Ewa Stuermer, Max J Zinser, Edmund A Neugebauer, Paul C Fuchs, Paola Koenen
    International Wound Journal.2015; 12(4): 387.     CrossRef
  • Genetic and cellular techniques emerge as promising modalities for the treatment of diabetic foot syndrome
    Vladimir Iosifovich Konenkov, Vadim Valerievich Klimontov
    Diabetes mellitus.2014; 17(1): 63.     CrossRef
  • Analysis of blood flow and local expression of angiogenesis-associated growth factors in infected wounds treated with negative pressure wound therapy
    CHENG-YAN XIA, AI-XI YU, BAIWEN QI, MIN ZHOU, ZONG-HUAN LI, WEI-YANG WANG
    Molecular Medicine Reports.2014; 9(5): 1749.     CrossRef
  • Alteration of Skin Properties with Autologous Dermal Fibroblasts
    Rajesh Thangapazham, Thomas Darling, Jon Meyerle
    International Journal of Molecular Sciences.2014; 15(5): 8407.     CrossRef
  • Angiopoietin-like 4 Stimulates STAT3-mediated iNOS Expression and Enhances Angiogenesis to Accelerate Wound Healing in Diabetic Mice
    Han Chung Chong, Jeremy Soon Kiat Chan, Chi Qin Goh, Natalia V Gounko, Baiwen Luo, Xiaoling Wang, Selin Foo, Marcus Thien Chong Wong, Cleo Choong, Sander Kersten, Nguan Soon Tan
    Molecular Therapy.2014; 22(9): 1593.     CrossRef
  • Genome Editing of Mouse Fibroblasts by Homologous Recombination for Sustained Secretion of PDGF-B and Augmentation of Wound Healing
    Jenny C. Barker, Adam D. Barker, Jessica Bills, Jiying Huang, Mary Wight-Carter, Imelda Delgado, Debby L. Noble, Lily J. Huang, Matthew H. Porteus, Kathryn E. Davis
    Plastic and Reconstructive Surgery.2014; 134(3): 389e.     CrossRef
The Effect of an Angiotensin Receptor Blocker on Arterial Stiffness in Type 2 Diabetes Mellitus Patients with Hypertension
Ji Hyun Kim, Su Jin Oh, Jung Min Lee, Eun Gyoung Hong, Jae Myung Yu, Kyung Ah Han, Kyung Wan Min, Hyun Shik Son, Sang Ah Chang
Diabetes Metab J. 2011;35(3):236-242.   Published online June 30, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.3.236
  • 28,954 View
  • 35 Download
  • 7 Crossref
AbstractAbstract PDFPubReader   
Background

Hypertension and type 2 diabetes mellitus are major risk factors for cardiovascular disease. This study analyzed the changes in central aortic waveforms and pulse wave velocity as well as related parameters after treatment with valsartan, an angiotensin II type 1 receptor blocker, in patients with type 2 diabetes and hypertension.

Methods

We used pulse wave analysis to measure central aortic waveform in a total of 98 subjects. In 47 of these patients, pulse wave velocity measurements were obtained before and after 12 weeks of treatment with valsartan.

Results

In the central aortic waveform analysis, the aortic pulse pressure and augmentation index were significantly decreased after valsartan treatment, as was the aortic pulse wave velocity. Factors contributing to the improvement in pulse wave velocity were the fasting blood glucose and haemoglobin A1c levels.

Conclusion

Short-term treatment with valsartan improves arterial stiffness in patients with type 2 diabetes and hypertension, and the glucose status at baseline was associated with this effect.

Citations

Citations to this article as recorded by  
  • Mechanisms underlying the blood pressure‐lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial
    Rosalie A. Scholtes, Charlotte M. Mosterd, Anne C. Hesp, Mark M. Smits, Hiddo J. L. Heerspink, Daniël H. van Raalte
    Diabetes, Obesity and Metabolism.2023; 25(1): 198.     CrossRef
  • Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome
    Ami B Bhatt, J Stewart Buck, Jonah P Zuflacht, Jessica Milian, Samoneh Kadivar, Kimberlee Gauvreau, Michael N Singh, Mark A Creager
    Vascular Medicine.2015; 20(4): 317.     CrossRef
  • The impact of angiotensin receptor blockers on arterial stiffness: a meta-analysis
    Feng Peng, Hongming Pan, Bin Wang, Jinxiu Lin, Wenquan Niu
    Hypertension Research.2015; 38(9): 613.     CrossRef
  • Arterial stiffness in atherosclerotic renovascular hypertension
    Ljiljana Fodor, Vedran Premužić, Vanja Ivković, Dražen Perkov, Mario Laganović, Tajana Željković Vrkić, Živka Dika, Marijana Živko, Bojan Jelaković
    Journal of Hypertension.2014; 32(11): 2238.     CrossRef
  • Improvement of arterial wall characteristics by the low-dose fluvastatin and valsartan combination in type 1 diabetes mellitus patients
    Vedran Savić, Barbara Eržen, Miodrag Janić, Mojca Lunder, Maja Boncelj, Karin Kanc, Andrej Janež, Mišo Šabovič
    Diabetes and Vascular Disease Research.2013; 10(5): 420.     CrossRef
  • The association between regional arterial stiffness and diabetic retinopathy in type 2 diabetes
    Won Jun Kim, Cheol-Young Park, Se Eun Park, Eun Jung Rhee, Won Young Lee, Ki Won Oh, Sung Woo Park, Sun Woo Kim, SuJeong Song
    Atherosclerosis.2012; 225(1): 237.     CrossRef
  • Letter: The Effect of an Angiotensin Receptor Blocker on Arterial Stiffness in Type 2 Diabetes Mellitus Patients with Hypertension (Diabetes Metab J 2011;35:236-42)
    Chul-Hee Kim
    Diabetes & Metabolism Journal.2011; 35(4): 427.     CrossRef
Angiotensin II Inhibits Insulin Binding to Endothelial Cells
Su-Jin Oh, Won-Chul Ha, Jee-In Lee, Tae-Seo Sohn, Ji-Hyun Kim, Jung-Min Lee, Sang-Ah Chang, Oak-Kee Hong, Hyun-Shik Son
Diabetes Metab J. 2011;35(3):243-247.   Published online June 30, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.3.243
  • 3,822 View
  • 24 Download
  • 6 Crossref
AbstractAbstract PDFPubReader   
Background

Insulin-mediated glucose uptake in insulin target tissues is correlated with interstitial insulin concentration, rather than plasma insulin concentration. Therefore, insulin delivery to the interstitium of target tissues is very important, and the endothelium may also play an important role in the development of insulin resistance.

Methods

After treating bovine aortic endothelial cells with angiotensin II (ATII), we observed the changes in insulin binding capacity and the amounts of insulin receptor (IR) on the cell membranes and in the cytosol.

Results

After treatment of 10-7M ATII, insulin binding was decreased progressively, up to 60% at 60 minutes (P<0.05). ATII receptor blocker (eprosartan) dose dependently improved the insulin binding capacity which was reduced by ATII (P<0.05). At 200 µM, eprosartan fully restored insulin binding capacity, althogh it resulted in only a 20% to 30% restoration at the therapeutic concentration. ATII did not affect the total amount of IR, but it did reduce the amount of IR on the plasma membrane and increased that in the cytosol.

Conclusion

ATII decreased the insulin binding capacity of the tested cells. ATII did not affect the total amount of IR but did decrease the amount of IR on the plasma membrane. Our data indicate that ATII decreases insulin binding by translocating IR from the plasma membrane to the cytosol. The binding of insulin to IR is important for insulin-induced vasodilation and transendothelial insulin transport. Therefore, ATII may cause insulin resistance through this endothelium-based mechanism.

Citations

Citations to this article as recorded by  
  • Acute, local infusion of angiotensin II impairs microvascular and metabolic insulin sensitivity in skeletal muscle
    Dino Premilovac, Emily Attrill, Stephen Rattigan, Stephen M Richards, Jeonga Kim, Michelle A Keske
    Cardiovascular Research.2019; 115(3): 590.     CrossRef
  • Angiotensin II type 2 receptor inhibits expression and function of insulin receptor in rat renal proximal tubule cells
    Yang Yang, Caiyu Chen, Chunjiang Fu, Zaicheng Xu, Cong Lan, Yongchun Zeng, Zhi Chen, Pedro A. Jose, Ye Zhang, Chunyu Zeng
    Journal of the American Society of Hypertension.2018; 12(2): 135.     CrossRef
  • Endothelial function, its relation to arterial hypertension and the possibility of its modulation
    Vladislav Biel, Jan Novák, Luděk Pluháček, Jiří Špác
    Vnitřní lékařství.2018; 64(7-8): 762.     CrossRef
  • Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer’s Disease
    Juan M. Saavedra
    Cellular and Molecular Neurobiology.2016; 36(2): 259.     CrossRef
  • Ameliorative effect of eprosartan on high-fat diet/streptozotocin-induced early diabetic nephropathy in rats
    Mohamed A. Morsy, Gehan H. Heeba, Magda E. Mahmoud
    European Journal of Pharmacology.2015; 750: 90.     CrossRef
  • Metabolic actions of angiotensin II and insulin: A microvascular endothelial balancing act
    Ranganath Muniyappa, Sahzene Yavuz
    Molecular and Cellular Endocrinology.2013; 378(1-2): 59.     CrossRef
Relationship between Chemerin Levels and Cardiometabolic Parameters and Degree of Coronary Stenosis in Korean Patients with Coronary Artery Disease
Yu-Jin Hah, Nam-Keong Kim, Mi-Kyung Kim, Hye-Soon Kim, Seung-Ho Hur, Hyuck-Jun Yoon, Yoon-Nyun Kim, Keun-Gyu Park
Diabetes Metab J. 2011;35(3):248-254.   Published online June 30, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.3.248
  • 24,772 View
  • 30 Download
  • 40 Crossref
AbstractAbstract PDFPubReader   
Background

Chemerin is a novel adipokine that is associated with inflammation and adipogenesis. However, it remains unclear whether chemerin is involved in patients with cardiovascular disease. We investigated whether the serum chemerin levels of Korean patients with coronary artery disease correlated with specific cardiometabolic parameters.

Methods

In total, 131 patients, all of whom had coronary artery stenosis exceeding 50%, participated in this study. Their serum chemerin levels and cardiometabolic parameters were measured. The serum chemerin levels of two groups of patients were compared; those with one stenotic vessel (n=68) and those with multiple stenotic vessels, including left main coronary artery disease (n=63).

Results

Serum chemerin levels correlated positively with the degree of coronary artery stenosis and fasting glucose, triglyceride, total cholesterol, low density lipoprotein cholesterol, and high sensitive C-reactive protein levels. The group with multiple stenotic vessels, including left main disease, had higher chemerin levels than the group with one stenotic vessel (t=-2.129, P=0.035). Multiple binary logistic regression showed chemerin was not an independent risk factor of multiple vessel disease (odds ratio, 1.018; confidence interval, 0.997 to 1.040; P=0.091).

Conclusion

Serum chemerin levels have a significant correlation with several cardiometabolic risk factors and the degree of coronary artery stenosis in Korean patients with coronary artery disease. However, multiple binary logistic regression showed chemerin was not an independent risk factor of multiple vessel disease. Additional investigations are necessary to fully elucidate the role of chemerin in cardiovascular disease.

Citations

Citations to this article as recorded by  
  • Adipokine chemerin overexpression in trophoblasts leads to dyslipidemia in pregnant mice: implications for preeclampsia
    Lunbo Tan, Zijun Ouyang, Zhilong Chen, Fen Sun, Haichun Guo, Feng Wang, Monique Mulder, Yuan Sun, Xifeng Lu, Jian V. Zhang, A. H. Jan Danser, Koen Verdonk, Xiujun Fan, Qing Yang
    Lipids in Health and Disease.2023;[Epub]     CrossRef
  • Chemerin Levels in Acute Coronary Syndrome: Systematic Review and Meta-Analysis
    Abdulrahman Ismaiel, Mohammad Zeeshan Ashfaq, Daniel-Corneliu Leucuta, Mohamed Ismaiel, Dilara Ensar Ismaiel, Stefan-Lucian Popa, Dan L Dumitrascu
    Laboratory Medicine.2022; 53(6): 552.     CrossRef
  • Prognostic value of plasma adipokine chemerin in patients with coronary artery disease
    Bo Wang, Wenxin Kou, Shuya Ji, Rongrong Shen, Hongwei Ji, Jianhui Zhuang, Yifan Zhao, Bo Li, Wenhui Peng, Xuejing Yu, Hailing Li, Yawei Xu
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • Role of Chemerin in Cardiovascular Diseases
    Mirjana T. Macvanin, Manfredi Rizzo, Jelena Radovanovic, Alper Sonmez, Francesco Paneni, Esma R. Isenovic
    Biomedicines.2022; 10(11): 2970.     CrossRef
  • Chemerin in inflammatory diseases
    Xin Su, Ye Cheng, Guoming Zhang, Bin Wang
    Clinica Chimica Acta.2021; 517: 41.     CrossRef
  • Chemerin activity in selected pathological states of human body – A systematic review
    Magdalena Acewicz, Irena Kasacka
    Advances in Medical Sciences.2021; 66(2): 270.     CrossRef
  • Chemerin in atherosclerosis
    Jia-Xiang Sun, Chi Zhang, Zhe-Bin Cheng, Mu-Yao Tang, Yi-Zhang Liu, Jie-Feng Jiang, Xuan Xiao, Liang Huang
    Clinica Chimica Acta.2021; 520: 8.     CrossRef
  • Serum Chemerin Concentration Is Associated with Proinflammatory Status in Chronic Coronary Syndrome
    Anna Szpakowicz, Malgorzata Szpakowicz, Magda Lapinska, Marlena Paniczko, Slawomir Lawicki, Andrzej Raczkowski, Marcin Kondraciuk, Emilia Sawicka, Malgorzata Chlabicz, Marcin Kozuch, Maciej Poludniewski, Slawomir Dobrzycki, Irina Kowalska, Karol Kaminski
    Biomolecules.2021; 11(8): 1149.     CrossRef
  • Novo Efeito Cardioprotetor da L-Carnitina em Camundongos Obesos Diabéticos: Regulação da Expressão de Quemerina e CMKLRI no Coração e Tecidos Adiposos
    Rezvan Amiri, Mohammad Reza Tabandeh, Seyed Ahmad Hosseini
    Arquivos Brasileiros de Cardiologia.2021; 117(4): 715.     CrossRef
  • The role of adipokines in the regulation of cardiovascular function
    A. V. Karpushev, V. B. Mikhailova
    "Arterial’naya Gipertenziya" ("Arterial Hypertension").2020; 25(5): 448.     CrossRef
  • The associations among RARRES2 rs17173608 gene polymorphism, serum chemerin, and non-traditional lipid profile in patients with metabolic syndrome
    Marwa A. Dahpy, Marwa K. Khairallah, Nashwa Mostafa A. Azoz, Ghada M. Ezzat
    Egyptian Journal of Medical Human Genetics.2020;[Epub]     CrossRef
  • Serum chemerin as a predictor of left ventricle hypertrophy in patients with coronary artery disease
    NohaHasssanin Hanboly, Yasser Sharaf, Mervat Al-Anany, Essam Saeed
    Nigerian Journal of Cardiology.2019; 16(1): 25.     CrossRef
  • Association of Circulating Chemerin With Subclinical Parameters of Atherosclerosis
    Stephanie Zylla, Marcus Dörr, Henry Völzke, Ulf Schminke, Stephan B. Felix, Matthias Nauck, Nele Friedrich
    Arteriosclerosis, Thrombosis, and Vascular Biology.2018; 38(7): 1656.     CrossRef
  • Six weeks of combined aerobic and resistance exercise using outdoor exercise machines improves fitness, insulin resistance, and chemerin in the Korean elderly: A pilot randomized controlled trial
    Dong-Il Kim, Dong Hoon Lee, Sunghyun Hong, Sung-won Jo, Young-shin Won, Justin Y. Jeon
    Archives of Gerontology and Geriatrics.2018; 75: 59.     CrossRef
  • Relationship between serum chemerin levels and insulin resistance index and cardio–respiratory function in non–active obese and lean men
    Mehdi Abbaszadegan, Farhad Kouhi achachluie
    Advances in Obesity, Weight Management & Control.2018;[Epub]     CrossRef
  • Serum levels of chemerin, apelin, vaspin, and omentin-1 in obese type 2 diabetic Egyptian patients with coronary artery stenosis
    Tarek M.K. Motawi, Soliman G. Mahdy, Maha M. El-Sawalhi, Eman N. Ali, Rania Farag A. El-Telbany
    Canadian Journal of Physiology and Pharmacology.2018; 96(1): 38.     CrossRef
  • Plasma CXCL1 levels and TRAF3IP2 variants in patients with myocardial infarction
    Safoora Pordel, Mahdi Sajedi Khanian, Mohammad Hossein Karimi, Hossein Nikoo, Mehrnoosh Doroudchi
    Journal of Clinical Laboratory Analysis.2018;[Epub]     CrossRef
  • Serum Chemerin Levels are Associated with Visceral Adiposity, Independent of Waist Circumference, in Newly Diagnosed Type 2 Diabetic Subjects
    Dae Young Cheon, Jun Goo Kang, Seong Jin Lee, Sung Hee Ihm, Eun Jig Lee, Moon Gi Choi, Hyung Joon Yoo, Chul Sik Kim
    Yonsei Medical Journal.2017; 58(2): 319.     CrossRef
  • The comparison of chemerin, adiponectin and lipid profile indices in obese and non-obese adolescents
    Zahra Maghsoudi, Roya Kelishadi, Mohammad Javad Hosseinzadeh-Attar
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2016; 10(2): S43.     CrossRef
  • Chemerin processing in the myocardium: A mechanism in search of a function
    Michael V.G. Latronico, Gianluigi Condorelli
    Journal of Molecular and Cellular Cardiology.2016; 100: 21.     CrossRef
  • Chemerin as an independent predictor of cardiovascular event risk
    Sinan İnci, Gökhan Aksan, Pınar Doğan
    Therapeutic Advances in Endocrinology and Metabolism.2016; 7(2): 57.     CrossRef
  • Chemerin level in pregnancies complicated by preeclampsia and its relation with disease severity and neonatal outcomes
    Orkun Cetin, Zehra Kurdoglu, Mertihan Kurdoglu, H. Guler Sahin
    Journal of Obstetrics and Gynaecology.2016; : 1.     CrossRef
  • Chemerin in renal dysfunction and cardiovascular disease
    Mario Bonomini, Assunta Pandolfi
    Vascular Pharmacology.2016; 77: 28.     CrossRef
  • High plasma chemerin is associated with renal dysfunction and predictive for cardiovascular events — Insights from phenotype and genotype characterization
    Andreas Leiherer, Axel Muendlein, Elena Kinz, Alexander Vonbank, Philipp Rein, Peter Fraunberger, Cornelia Malin, Christoph H. Saely, Heinz Drexel
    Vascular Pharmacology.2016; 77: 60.     CrossRef
  • Chemerin plays a protective role by regulating human umbilical vein endothelial cell-induced nitric oxide signaling in preeclampsia
    Liqiong Wang, Tianli Yang, Yiling Ding, Yan Zhong, Ling Yu, Mei Peng
    Endocrine.2015; 48(1): 299.     CrossRef
  • Evaluation of the salivary levels of visfatin, chemerin, and progranulin in periodontal inflammation
    Erkan Özcan, N. Işıl Saygun, Muhittin A. Serdar, Nezahat Kurt
    Clinical Oral Investigations.2015; 19(4): 921.     CrossRef
  • Elevated serum chemerin in Chinese women with hyperandrogenic PCOS
    LiQiong Wang, Yan Zhong, YiLing Ding, XiaoBo Shi, Jian Huang, FuFan Zhu
    Gynecological Endocrinology.2014; 30(10): 746.     CrossRef
  • Chemerin reduces vascular nitric oxide/cGMP signalling in rat aorta: a link to vascular dysfunction in obesity?
    Karla Bianca Neves, Núbia S. Lobato, Rhéure Alves Moreira Lopes, Fernando P. Filgueira, Camila Ziliotto Zanotto, Ana Maria Oliveira, Rita C. Tostes
    Clinical Science.2014; 127(2): 111.     CrossRef
  • Chemerin levels as predictor of acute coronary events: A case–control study nested within the veterans affairs normative aging study
    Konstantinos N. Aronis, Ayse Sahin-Efe, John P. Chamberland, Avron Spiro, Pantel Vokonas, Christos S. Mantzoros
    Metabolism.2014; 63(6): 760.     CrossRef
  • The predictive value of the first-trimester maternal serum chemerin level for pre-eclampsia
    Qiu-Lian Xu, Min Zhu, Yan Jin, Nan Wang, Hai-Xia Xu, Li-Mei Quan, Shan-Shan Wang, Shan-Shan Li
    Peptides.2014; 62: 150.     CrossRef
  • Evaluation of Circulating Adipokines and Abdominal Obesity as Predictors of Significant Myocardial Ischemia Using Gated Single-Photon Emission Computed Tomography
    Chi-Sheng Hung, Yen-Wen Wu, Jei-Yie Huang, Pei-Ying Hsu, Ming-Fong Chen, Xin-Liang Ma
    PLoS ONE.2014; 9(5): e97710.     CrossRef
  • Towards an integrative approach to understanding the role of chemerin in human health and disease
    J. L. Rourke, H. J. Dranse, C. J. Sinal
    Obesity Reviews.2013; 14(3): 245.     CrossRef
  • The association between chemerin and homeostasis assessment of insulin resistance at baseline and after weight reduction via lifestyle modifications in young obese adults
    Mi Kyung Lee, Sang Hui Chu, Duk Chul Lee, Ki Yong An, Ji-Hye Park, Dong Il Kim, Jiyoung Kim, Sunghyun Hong, Jee Aee Im, Ji Won Lee, Justin Y. Jeon
    Clinica Chimica Acta.2013; 421: 109.     CrossRef
  • Elevated Chemerin Levels in Pakistani Men: An Interrelation with Metabolic Syndrome Phenotypes
    Syeda Sadia Fatima, Kiymet Bozaoglu, Rehana Rehman, Faiza Alam, Abdul Shakoor Memon, Pascale Chavatte-Palmer
    PLoS ONE.2013; 8(2): e57113.     CrossRef
  • Chemerin: a potential endocrine link between obesity and type 2 diabetes
    Alexandra A. Roman, Sebastian D. Parlee, Christopher J. Sinal
    Endocrine.2012; 42(2): 243.     CrossRef
  • Elastase and Tryptase Govern TNFα-Mediated Production of Active Chemerin by Adipocytes
    Sebastian D. Parlee, Jenna O. McNeil, Shanmugam Muruganandan, Christopher J. Sinal, Kerry B. Goralski, Charaf Benarafa
    PLoS ONE.2012; 7(12): e51072.     CrossRef
  • Potential association between coronary artery disease and the inflammatory biomarker YKL-40 in asymptomatic patients with type 2 diabetes mellitus
    Hyun Min Kim, Byung-Wan Lee, Young-Mi Song, Won Jin Kim, Hyuk-Jae Chang, Dong-Hoon Choi, Hee Tae Yu, EunSeok Kang, Bong Soo Cha, Hyun Chul Lee
    Cardiovascular Diabetology.2012;[Epub]     CrossRef
  • The association of serum chemerin level with risk of coronary artery disease in Chinese adults
    Qun Yan, Yifei Zhang, Jie Hong, Weiqiong Gu, Meng Dai, Juan Shi, Ying Zhai, Weiqing Wang, Xiaoying Li, Guang Ning
    Endocrine.2012; 41(2): 281.     CrossRef
  • Epidemiology of Micro- and Macrovascular Complications of Type 2 Diabetes in Korea
    Jung Hee Kim, Dae Jung Kim, Hak Chul Jang, Sung Hee Choi
    Diabetes & Metabolism Journal.2011; 35(6): 571.     CrossRef
  • Chemerin: A Novel Link between Inflammation and Atherosclerosis?
    Eun-Jung Rhee
    Diabetes & Metabolism Journal.2011; 35(3): 216.     CrossRef
Prevalence of Diabetes Mellitus and Prediabetes in Dalseong-gun, Daegu City, Korea
Jung-Eun Lee, Sung-Chang Jung, Gui-Hwa Jung, Sung-Woo Ha, Bo-Wan Kim, Shung-Chull Chae, Wee-Hyun Park, Ji-Sun Lim, Jin-Hoon Yang, Sin Kam, Byung-Yeol Chun, Jong-Yeon Kim, Jung-Jeung Lee, Kyeong-Soo Lee, Moon-Young Ahn, Young-Ae Kim, Jung-Guk Kim
Diabetes Metab J. 2011;35(3):255-263.   Published online June 30, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.3.255
  • 4,865 View
  • 37 Download
  • 9 Crossref
AbstractAbstract PDFPubReader   
Background

The aim of the present study was to determine the population-based prevalence of diabetes mellitus (DM) and prediabetes in a rural district of Daegu City, Korea.

Methods

Between August and November 2003, a community-based health survey of adults aged 20 years and older was performed in the rural district of Dalseong-gun in Daegu City. A total of 1,806 of all eligible individuals agreed to participate. Fasting plasma glucose was measured in all participants. Two hour oral glucose tolerance was measured in the 1,773 participants for whom there was neither an established diagnosis of DM nor evidence of DM according to fasting glucose levels. The prevalence of DM and prediabetes was determined according to the 2003 criteria of the American Diabetes Association. Subjects with prediabetes were classified into one of three categories of glucose intolerance: isolated impaired fasting glucose (IFG); isolated impaired glucose tolerance (IGT); or combined IFG and IGT.

Results

The prevalence of DM was 12.2%. The highest prevalence rates were observed in subjects in their seventies. A total of 34.7% of all subjects who were assigned a diagnosis of DM in the present study had not been diagnosed previously. The prevalence of prediabetes was 22.7%. The highest prevalence rates were observed in subjects in their fifties.

Conclusion

The present study identified prevalence rates of 12.2% for DM (age-standardized prevalence rate [ASR], 6.8%), and 22.7% for prediabetes (ASR 18.5%). These results emphasize the need for community health promotion strategies to prevent or delay the onset of DM in individuals with prediabetes.

Citations

Citations to this article as recorded by  
  • Rural-urban differentials of prevalence and lifestyle determinants of pre-diabetes and diabetes among the elderly in southwest China
    Yi Zhao, Hui-fang Li, Xia Wu, Guo-hui Li, Allison Rabkin Golden, Le Cai
    BMC Public Health.2023;[Epub]     CrossRef
  • The Prevalence of Diabetes, Prediabetes and Associated Risk Factors in Hangzhou, Zhejiang Province: A Community-Based Cross-Sectional Study
    Mingming Shi, Xiao Zhang, Hui Wang
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 713.     CrossRef
  • Epidemiology of Isolated Impaired Glucose Tolerance Among Adults Aged Above 50 Years in Rural China
    Xiaobing Tian, Yan Li, Jie Liu, Qiuxing Lin, Qiaoxia Yang, Jun Tu, Jinghua Wang, Jidong Li, Xianjia Ning
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 4067.     CrossRef
  • Association between Frequency of Breakfast Consumption and Insulin Resistance Using Triglyceride-Glucose Index: A Cross-Sectional Study of the Korea National Health and Nutrition Examination Survey (2016–2018)
    Hye Jin Joo, Gyu Ri Kim, Eun-Cheol Park, Sung-In Jang
    International Journal of Environmental Research and Public Health.2020; 17(9): 3322.     CrossRef
  • The prevalence of prediabetes and associated conditions in Ahmedabad population
    Bhoomi Arora, Snehal S. Patel, Banshi D. Saboo
    International Journal of Diabetes in Developing Countries.2020; 40(1): 61.     CrossRef
  • STUDY OF DYSLIPIDAEMIA AMONG PRE-DIABETIC PATIENTS
    Ravikumar Ravikumar, Gopal Krishnamurthy S. N, Anil Kumar T., Ashwin Kulkarni, Bhavanashree Magaji, Gayatri Sujive
    Journal of Evidence Based Medicine and Healthcare.2019; 6(36): 2480.     CrossRef
  • Prevalence of Pre-Diabetes across Ethnicities: A Review of Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) for Classification of Dysglycaemia
    Wilson Yip, Ivana Sequeira, Lindsay Plank, Sally Poppitt
    Nutrients.2017; 9(11): 1273.     CrossRef
  • Epidemiology of abnormal glucose metabolism in a country facing its epidemic: SAUDI‐DM study
    Khalid Al‐Rubeaan, Hamad A. Al‐Manaa, Tawfik A. Khoja, Najlaa A. Ahmad, Ahmad H. Al‐Sharqawi, Khalid Siddiqui, Dehkra Alnaqeb, Khaled H. Aburisheh, Amira M. Youssef, Abdullah Al‐Batel, Metib S. Alotaibi, Ali A. Al‐Gamdi
    Journal of Diabetes.2015; 7(5): 622.     CrossRef
  • Association of Adiposity Trajectories With Insulin Sensitivity and Glycemic Deterioration
    Rong Liu, Wendy J. Brickman, Katherine K. Christoffel, Xin Liu, Guoying Wang, Lester Arguelles, Shanchun Zhang, Donald Zimmerman, Binyan Wang, Xiping Xu, Zhiping Li, Houxun Xing, Xiaobin Wang
    Diabetes Care.2012; 35(7): 1506.     CrossRef
Therapeutic Target Achievement in Type 2 Diabetic Patients after Hyperglycemia, Hypertension, Dyslipidemia Management
Ah Young Kang, Su Kyung Park, So Young Park, Hye Jeong Lee, Ying Han, Sa Ra Lee, Sung Hwan Suh, Duk Kyu Kim, Mi Kyoung Park
Diabetes Metab J. 2011;35(3):264-272.   Published online June 30, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.3.264
  • 10,056 View
  • 35 Download
  • 12 Crossref
AbstractAbstract PDFPubReader   
Background

Our study group established "3H care" in 2002. The meaning of "3H care" attain and maintain adequate controls over hypertension, hyperlipidemia, and hyperglycemia in type 2 diabetic patients. This study evaluated the achievement of target goals after one year or more of "3H care" by specialists in our diabetic clinic.

Methods

This was a retrospective study of 200 type 2 diabetic patients who received "3H care" for one year or more in our diabetic clinic. We evaluated achievement of target goals for metabolic controls as suggested by the American Diabetes Association.

Results

Overall, 200 type 2 diabetes patients were enrolled, of whom 106 were males (53%) and 94 were females (47%). After one year of "3H care," the mean HbA1c was 7.2±1.5% and the percentage of patients achieving glycemic control (HbA1c <7%) was 51.8%. However only 32.2% of hypertensive patients achieved the recommended target. After one year of "3H care," the percentages of those who achieved the target value for dyslipidemia were 80.0% for total cholesterol, 66.3% for low density lipoprotein cholesterol, 57.9% for triglyceride, and 51.8% for high density lipoprotein cholesterol. The percentage that achieved all three targets level was only 4.4% after one year and 14.8% after two years.

Conclusion

The results of this study demonstrate that only a minor proportion of patients with type 2 diabetes achieved the recommended goals despite the implementation of "3H care." It is our suggestion that better treatment strategies and methods should be used to control hypertension, hyperlipidemia and hyperglycemia.

Citations

Citations to this article as recorded by  
  • Achievement of the ABC goal among Canadians with type 2 diabetes and the influence of physical activity: data from the Canadian Health Measures Survey
    Alexis Marcotte-Chénard, René Maréchal, Ahmed Ghachem, Alan Cohen, Eléonor Riesco
    Applied Physiology, Nutrition, and Metabolism.2023; 48(9): 657.     CrossRef
  • Poor Adherence to Common Recommendations and Associated Factors among Outpatients with Type 2 Diabetes Mellitus in a Police Hospital of Ethiopia
    Tariku Shimels, Melesse Abebaw, Gebremedhin Beedemariam Gebretekle
    Journal of Social Health and Diabetes.2021; 9(01): e8.     CrossRef
  • Prevalence and correlation of glycemic control achievement in patients with type 2 diabetes in Iraq: A retrospective analysis of a tertiary care database over a 9-year period
    Abbas Ali Mansour, Nassar T.Y. Alibrahim, Haider A. Alidrisi, Ali H. Alhamza, Ammar M. Almomin, Ibrahim Abbood Zaboon, Muayad Baheer Kadhim, Rudha Naser Hussein, Hussein Ali Nwayyir, Adel Gassab Mohammed, Dheyaa K.J. Al-Waeli, Ibrahim Hani Hussein
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2020; 14(3): 265.     CrossRef
  • Notoginsenoside R1 Ameliorates Diabetic Retinopathy through PINK1-Dependent Activation of Mitophagy
    Ping Zhou, Weijie Xie, Xiangbao Meng, Yadong Zhai, Xi Dong, Xuelian Zhang, Guibo Sun, Xiaobo Sun
    Cells.2019; 8(3): 213.     CrossRef
  • Association of Self-Reported Dietary and Drug Compliance with Optimal Metabolic Control in Patients with Type 2 Diabetes: Clinic-Based Single-Center Study in a Developing Country
    Thilak Priyantha Weerarathna, Miyuru Kavinda Weerarathna, Vidarsha Senadheera, Herath Mudiyanselage Meththananda Herath, Gayani Liyanage
    Journal of Nutrition and Metabolism.2018; 2018: 1.     CrossRef
  • Prevalence of primary aldosteronism among patients with type 2 diabetes
    Mauro Tancredi, Gudmundur Johannsson, Björn Eliasson, Robert Eggertsen, Ulf Lindblad, Sofia Dahlqvist, Henrik Imberg, Marcus Lind
    Clinical Endocrinology.2017; 87(3): 233.     CrossRef
  • GS-E3D, a new pectin lyase-modified red ginseng extract, inhibited diabetes-related renal dysfunction in streptozotocin-induced diabetic rats
    Chan-Sik Kim, Kyuhyung Jo, Jin Sook Kim, Mi-Kyung Pyo, Junghyun Kim
    BMC Complementary and Alternative Medicine.2017;[Epub]     CrossRef
  • Ursodeoxycholic acid and 4-phenylbutyrate prevent endoplasmic reticulum stress-induced podocyte apoptosis in diabetic nephropathy
    Ai-Li Cao, Li Wang, Xia Chen, Yun-Man Wang, Heng-Jiang Guo, Shuang Chu, Cheng Liu, Xue-Mei Zhang, Wen Peng
    Laboratory Investigation.2016; 96(6): 610.     CrossRef
  • Ursodeoxycholic Acid Ameliorated Diabetic Nephropathy by Attenuating Hyperglycemia-Mediated Oxidative Stress
    Aili Cao, Li Wang, Xia Chen, Hengjiang Guo, Shuang Chu, Xuemei Zhang, Wen Peng
    Biological & Pharmaceutical Bulletin.2016; 39(8): 1300.     CrossRef
  • Withania coagulansFruit Extract Reduces Oxidative Stress and Inflammation in Kidneys of Streptozotocin-Induced Diabetic Rats
    Shreesh Ojha, Juma Alkaabi, Naheed Amir, Azimullah Sheikh, Ahmad Agil, Mohamed Abdelmonem Fahim, Abdu Adem
    Oxidative Medicine and Cellular Longevity.2014; 2014: 1.     CrossRef
  • Assessment of cardiometabolic risk and prevalence of meeting treatment guidelines among patients with type 2 diabetes stratified according to their use of insulin and/or other diabetic medications: results from INSPIRE ME IAA
    J. Smith, J.‐A. Nazare, A.‐L. Borel, P. Aschner, P. J. Barter, L. Van Gaal, Y. Matsuzawa, T. Kadowaki, R. Ross, C. Brulle‐Wohlhueter, N. Alméras, S. M. Haffner, B. Balkau, J.‐P. Després
    Diabetes, Obesity and Metabolism.2013; 15(7): 629.     CrossRef
  • Are PPAR alpha agonists a rational therapeutic strategy for preventing abnormalities of the diabetic kidney?
    Pitchai Balakumar, Supriya Kadian, Nanjaian Mahadevan
    Pharmacological Research.2012; 65(4): 430.     CrossRef
Small Rice Bowl-Based Meal Plan for Energy and Marcronutrient Intake in Korean Men with Type 2 Diabetes: A Pilot Study
Hee Jung Ahn, Kyung Ah Han, Jin Young Jang, Jae Hyuk Lee, Kang Seo Park, Kyung Wan Min
Diabetes Metab J. 2011;35(3):273-281.   Published online June 30, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.3.273
  • 65,535 View
  • 37 Download
  • 3 Crossref
AbstractAbstract PDFPubReader   
Background

Koreans eat rice, which is usually served in a rice bowl. We investigated the effect of a meal plan using small rice bowls on the total energy intake (TEI) and the marcronutrient intake in Korean men with type 2 diabetes.

Methods

A total of 62 men with type 2 diabetes were divided by body mass index (BMI) (normal weight [NW], BMI<23 kg/m2; overweight [OW], 23≤BMI<25 kg/m2; obese [OB], BMI≥25 kg/m2) and proportions of carbohydrate intake to TEI (PCI) (low carbohydrate intake [LC], <55%; recommended carbohydrate intake [RC], ≥55% and ≤60%; high carbohydrate intake [HC], >60%). The 3-day dietary records were analyzed for TEI and proportions of macronutrients, before and 2 weeks after a small-sized (300 mL) rice bowl based education was given.

Results

There were no significant differences in the age and BMI within the sub-groups by BMI and PCI groups. In baseline, the ratio of TEI to recommended total energy intake (RTR) of OW and OB were higher than that of NW. The PCI of HC was higher than that of LC and alcohol intake of HC was lower than that of LC. After education, the reduction of RTREI in OB was higher than that in OW and NW. The reduction of PCI in HC was higher than that of LC.

Conclusion

A small rice bowl based meal plan was effective for the reduction of energy intake and control of marcronutrient intake in Korean obese men with type 2 diabetes consuming a high carbohydrate diet.

Citations

Citations to this article as recorded by  
  • Comprehensive Understanding for Application in Korean Patients with Type 2 Diabetes Mellitus of the Consensus Statement on Carbohydrate-Restricted Diets by Korean Diabetes Association, Korean Society for the Study of Obesity, and Korean Society of Hyperte
    Jong Han Choi, Jee-Hyun Kang, Suk Chon
    Diabetes & Metabolism Journal.2022; 46(3): 377.     CrossRef
  • The association between measurement sites of visceral adipose tissue and cardiovascular risk factors after caloric restriction in obese Korean women
    Hye-Ok Lee, Jung-Eun Yim, Jeong-Sook Lee, Young-Seol Kim, Ryowon Choue
    Nutrition Research and Practice.2013; 7(1): 43.     CrossRef
  • Daily Rice Intake Strongly Influences the Incidence of Metabolic Syndrome in Japanese Men Aged 40-59 Years
    Yoko Watanabe, Isao Saito, Yasuhiko Asada, Taro Kishida, Tatsuhiro Matsuo, Masamitsu Yamaizumi, Tadahiro Kato
    Journal of Rural Medicine.2013; 8(1): 161.     CrossRef
Factors Associated with Long-Term Oral Hypoglycemic Agent Responsiveness in Korean Patients with Type 2 Diabetes Mellitus
Bo-Yeon Kim, Chan-Hee Jung, Ji-Oh Mok, Chul-Hee Kim
Diabetes Metab J. 2011;35(3):282-289.   Published online June 30, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.3.282
  • 3,345 View
  • 28 Download
  • 4 Crossref
AbstractAbstract PDFPubReader   
Background

This study was performed to determine the factors associated with long-term oral hypoglycemic agent (OHA) responsiveness in Korean type 2 diabetic patients.

Methods

Two groups of patients were selected among the type 2 diabetic patients who were followed for more than two years at a university hospital diabetes clinic. The OHA responsive group consisted of 197 patients whose HbA1c levels were maintained at ≤7% with OHA for more than two years. The OHA failure group consisted of 180 patients whose HbA1c levels were >8% in spite of optimal combined OHA therapy or patients who required insulin therapy within the two years of the study.

Results

The OHA failure group had higher baseline values of fasting and postprandial glucose, HbA1c, and lower fasting, postprandial, and delta C-peptide compared to those of the OHA responsive group. The OHA failure group also had a higher proportion of female patients, longer diabetic duration, and more family history of diabetes. There were no significant differences in body mass index (BMI) or insulin resistance index between the two groups. Multiple logistic regression analysis showed that the highest quartile of baseline fasting, postprandial glucose, and HbA1c and the lowest quartile of postprandial and delta C-peptide were associated with an increased odds ratio of OHA failure after adjustment for age, sex, body mass index, and family history of diabetes.

Conclusion

Lower baseline values of postprandial and delta C-peptide and elevated fasting glucose and HbA1c are associated with long-term OHA responsiveness in Korean patients with type 2 diabetes mellitus.

Citations

Citations to this article as recorded by  
  • Therapeutic Effects of Switching to Anagliptin from Other DPP-4 Inhibitors in T2DM Patients with Inadequate Glycemic Control: A Non-interventional, Single-Arm, Open-Label, Multicenter Observational Study
    Sang-Yong Kim, Sungrae Kim
    Diabetes Therapy.2023; 14(1): 109.     CrossRef
  • Cyanidin-3-glucoside isolated from mulberry fruits protects pancreatic β-cells against glucotoxicity-induced apoptosis
    JONG SEOK LEE, YOUNG RAE KIM, JUN MYOUNG PARK, YOUNG EON KIM, NAM IN BAEK, EOCK KEE HONG
    Molecular Medicine Reports.2015; 11(4): 2723.     CrossRef
  • The Duration of Sulfonylurea Treatment Is Associated withβ-Cell Dysfunction in Patients with Type 2 Diabetes Mellitus
    Mi-Seon Shin, Jee Hee Yu, Chang Hee Jung, Jenie Yoonoo Hwang, Woo Je Lee, Min-Seon Kim, Joong-Yeol Park
    Diabetes Technology & Therapeutics.2012; 14(11): 1033.     CrossRef
  • The ratio of glycated albumin to glycated haemoglobin correlates with insulin secretory function
    Daham Kim, Kwang J. Kim, Ji H. Huh, Byung‐Wan Lee, Eun S. Kang, Bong S. Cha, Hyun C. Lee
    Clinical Endocrinology.2012; 77(5): 679.     CrossRef
Retrospective Analysis on the Efficacy, Safety and Treatment Failure Group of Sitagliptin for Mean 10-Month Duration
Won Jun Kim, Cheol-Young Park, Eun Haeng Jeong, Jeong Youn Seo, Ji Soo Seol, Se Eun Park, Eun Jung Rhee, Won Young Lee, Ki Won Oh, Sung Woo Park, Sun Woo Kim
Diabetes Metab J. 2011;35(3):290-297.   Published online June 30, 2011
DOI: https://doi.org/10.4093/dmj.2011.35.3.290
  • 4,303 View
  • 31 Download
  • 9 Crossref
AbstractAbstract PDFPubReader   
Background

To investigate the clinical results of sitagliptin (SITA) and the characteristics of the treatment failure group or of low responders to SITA.

Methods

A retrospective study of type 2 diabetic patients reviewed 99 cases, including 12 treatment failure cases, who stopped SITA because of worsening patients' condition, and 87 cases, who continued treatment over five visits (total 9.9±10.1 months) after receiving the prescription of SITA from December 2008 to June 2009. Subjects were classified as five groups administered SITA as an initial combination with metformin (MET), add-on to metformin or sulfonylurea, and switching from sulfonylurea or thiazolidinedione. The changes in HbA1c level from the first to last visit (ΔHbA1c) in treatment maintenance group were subanalyzed.

Results

The HbA1c level was significantly reduced in four groups, including initial coadministration of SITA with metformin (ΔHbA1c=-1.1%, P<0.001), add-on to MET (ΔHbA1c=-0.6%, P=0.017), add-on to sulfonylurea (ΔHbA1c=-0.5%, P<0.001), and switching from thiazolidinedione (ΔHbA1c=-0.3%, P=0.013). SITA was noninferior to sulfonlyurea (ΔHbA1c=-0.2%, P=0.63). There was no significant adverse effect. The treatment failure group had a longer diabeties duration (P=0.008), higher HbA1c (P=0.001) and fasting plasma glucose (P=0.003) compared to the maintenance group. Subanalysis on the tertiles of ΔHbA1c showed that low-response to SITA (tertile 1) was associated with a longer diabetes duration (P=0.009) and lower HbA1c (P<0.001).

Conclusion

SITA was effective and safe for use in Korean type 2 diabetic patients. However, its clinical responses and long-term benefit-harm profile is yet to be established.

Citations

Citations to this article as recorded by  
  • Development of a 13C Stable Isotope Assay for Dipeptidyl Peptidase-4 Enzyme Activity A New Breath Test for Dipeptidyl Peptidase Activity
    Roger Yazbeck, Simone Jaenisch, Michelle Squire, Catherine A. Abbott, Emma Parkinson-Lawrence, Douglas A. Brooks, Ross N. Butler
    Scientific Reports.2019;[Epub]     CrossRef
  • Characterization of changes in HbA1c in patients with and without secondary failure after metformin treatments by a population pharmacodynamic analysis using mixture models
    Yoko Tamaki, Kunio Maema, Makoto Kakara, Masato Fukae, Ryoko Kinoshita, Yushi Kashihara, Shota Muraki, Takeshi Hirota, Ichiro Ieiri
    Drug Metabolism and Pharmacokinetics.2018; 33(6): 264.     CrossRef
  • Effects of 6-Month Sitagliptin Treatment on Insulin and Glucagon Responses in Korean Patients with Type 2 Diabetes Mellitus
    Hae Kyung Yang, Borami Kang, Seung-Hwan Lee, Hun-Sung Kim, Kun-Ho Yoon, Bong-Yun Cha, Jae-Hyoung Cho
    Diabetes & Metabolism Journal.2015; 39(4): 335.     CrossRef
  • Clinical Characteristics and Metabolic Predictors of Rapid Responders to Dipeptidyl Peptidase-4 Inhibitor as an Add-on Therapy to Sulfonylurea and Metformin
    Ye An Kim, Won Sang Yoo, Eun Shil Hong, Eu Jeong Ku, Kyeong Seon Park, Soo Lim, Young Min Cho, Kyong Soo Park, Hak Chul Jang, Sung Hee Choi
    Diabetes & Metabolism Journal.2015; 39(6): 489.     CrossRef
  • Letter: Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J2015;39:342-7)
    Ye An Kim
    Diabetes & Metabolism Journal.2015; 39(5): 444.     CrossRef
  • Optimal Candidates for the Switch from Glimepiride to Sitagliptin to Reduce Hypoglycemia in Patients with Type 2 Diabetes Mellitus
    Hyun Min Kim, Jung Soo Lim, Byung-Wan Lee, Eun-Seok Kang, Hyun Chul Lee, Bong-Soo Cha
    Endocrinology and Metabolism.2015; 30(1): 84.     CrossRef
  • One-year real-life efficacy of sitagliptin revealed importance of concomitant pioglitazone use in Japanese patients with type 2 diabetes mellitus
    Ayako Suzuki, Nakayuki Yoshimura, Yamato Mashimo, Maiko Numakura, Yuko Fujimaki, Tomomi Maeda, Toshio Ishikawa, Shin Fujimori, Kazuhiro Eto
    Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2013; 7(3): 143.     CrossRef
  • Clinical Characteristics of the Responders to Dipeptidyl Peptidase-4 Inhibitors in Korean Subjects with Type 2 Diabetes
    Tae Jung Oh, Hye Seung Jung, Jae Hyun Bae, Yeong Gi Kim, Kyeong Seon Park, Young Min Cho, Kyong Soo Park, Seong Yeon Kim
    Journal of Korean Medical Science.2013; 28(6): 881.     CrossRef
  • Factors predicting therapeutic efficacy of combination treatment with sitagliptin and metformin in type 2 diabetic patients: the COSMETIC study
    Soo Lim, Jee Hyun An, Hayley Shin, Ah Reum Khang, Yenna Lee, Hwa Young Ahn, Ji Won Yoon, Seon Mee Kang, Sung Hee Choi, Young Min Cho, Kyong Soo Park, Hak Chul Jang
    Clinical Endocrinology.2012; 77(2): 215.     CrossRef
Letter

Diabetes Metab J : Diabetes & Metabolism Journal